{"meta":{"query_hash":"6cbc46beb1ad","filters":{"venue":"Cancer Research Communications"},"cohort_total":66,"direct_labels_cover":0,"predictions_cover":66,"exported":66,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6cbc46beb1ad","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Research+Communications"},"results":[{"id":"W3213169138","doi":"10.1158/2767-9764.crc-21-0064","title":"BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin","year":2021,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Kurozumi Medical Foundation; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Nakatomi Foundation","keywords":"Olaparib; Gene knockdown; Transactivation; Synthetic lethality; Poly ADP ribose polymerase; Cancer research; PARP inhibitor; Biology; Transcription factor; Molecular biology; RAD51; Homologous recombination; Chemistry; Cell culture; DNA repair; Gene; Genetics; Polymerase","score_opus":0.16309682700075723,"score_gpt":0.4551863214761788,"score_spread":0.2920894944754216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213169138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192554,0.0039807525,0.0024633964,0.00009806356,0.00002337826,0.000037734648,0.0005440935,0.00009992133,0.00082714815],"genre_scores_gemma":[0.9970823,0.000860099,0.0007923176,0.000044754037,0.00000677909,0.000025108162,0.000510497,0.000008994935,0.000669026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99977094,0.00003093491,0.000029976734,0.000057012174,0.00006385499,0.000047223122],"domain_scores_gemma":[0.99983263,0.000021833985,0.000075096956,0.000017283157,0.000022546756,0.00003059506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018381103,0.00033476177,0.0004267543,0.0003685213,0.00015433894,0.00029523426,0.00019643852,0.00032592547,0.00078956754],"category_scores_gemma":[0.00022190121,0.00017851507,0.00035795584,0.0002229733,0.0001724168,0.0002610554,0.00014728,0.0004907923,0.00019393871],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023405824,0.000049178387,0.0032973858,0.000068639834,0.000016929564,0.00013049711,0.000028032815,0.00014632137,0.9913299,0.000060558046,0.00008731367,0.004551208],"study_design_scores_gemma":[0.000018060558,0.0004607101,0.092574,0.000013797654,0.000047194975,0.0015188694,0.00006357729,0.001841132,0.9008519,0.0001286162,0.0024669087,0.000015237026],"about_ca_topic_score_codex":0.00032141482,"about_ca_topic_score_gemma":0.00025051017,"teacher_disagreement_score":0.00078956754,"about_ca_system_score_codex":0.0002465046,"about_ca_system_score_gemma":0.0001126904,"threshold_uncertainty_score":0.0026413202},"labels":[],"label_agreement":null},{"id":"W4200247581","doi":"10.1158/2767-9764.crc-21-0099","title":"Influence of Germline<i>BRCA</i>Genotype on the Survival of Patients with Triple-Negative Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute; Breast Cancer Research Foundation; Conquer Cancer Foundation; Avon Foundation for Women; American Cancer Society","keywords":"Triple-negative breast cancer; Breast cancer; Genotype; Germline; Oncology; Medicine; Triple negative; Internal medicine; Cancer; Biology; Genetics; Gene","score_opus":0.11314913289926067,"score_gpt":0.43653980548928767,"score_spread":0.323390672590027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200247581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934596,0.00020166692,0.000018153174,0.000046204586,0.0000058333667,0.0000010887874,0.000057401605,0.0000019792085,0.00032178068],"genre_scores_gemma":[0.9997631,0.000048202382,0.000010414937,0.000021439057,0.000008006409,0.000001051056,0.000074706884,0.0000011097258,0.00007206374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998361,0.00005247198,0.000011298166,0.00003528592,0.000020943073,0.000043810007],"domain_scores_gemma":[0.9991242,0.00034593782,0.00020918155,0.000057071444,0.00005417347,0.00020937315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035549758,0.00012793948,0.0002321012,0.00019688426,0.00023176818,0.00030492185,0.00012448695,0.00031866148,0.00090280565],"category_scores_gemma":[0.0018398593,0.00007601363,0.000331465,0.0002133165,0.00014611467,0.00018234731,0.00014836225,0.00030873576,0.000156215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011871175,0.000045874058,0.99290985,0.0000050164576,0.000066373184,0.00011706165,0.000039124046,0.00014334434,0.0006485875,0.00000871868,0.00014798601,0.0046809013],"study_design_scores_gemma":[0.000011980824,0.00032655068,0.99889034,0.0000031459165,0.000057634014,0.00018395719,0.000050012164,0.000216397,0.00007783994,0.000018295685,0.0001613963,0.0000025896761],"about_ca_topic_score_codex":0.002951065,"about_ca_topic_score_gemma":0.0033195869,"teacher_disagreement_score":0.002951065,"about_ca_system_score_codex":0.00023093613,"about_ca_system_score_gemma":0.00020764378,"threshold_uncertainty_score":0.0058677793},"labels":[],"label_agreement":null},{"id":"W4206023678","doi":"10.1158/2767-9764.crc-21-0032","title":"Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Head and neck squamous-cell carcinoma; PD-L1; Medicine; Oncology; Immune system; Biomarker; Immune checkpoint; Cancer research; Internal medicine; Immunotherapy; Head and neck cancer; Cancer; Immunology; Biology; Nivolumab","score_opus":0.094955199636439,"score_gpt":0.39300963255965166,"score_spread":0.29805443292321265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206023678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985519,0.0005314206,0.00043076693,0.000007721683,0.0000021973322,0.000028510933,0.00023300068,0.000009219565,0.00020533177],"genre_scores_gemma":[0.9985299,0.00012836412,0.00050760375,0.0000120276645,0.0000045059887,0.00007746845,0.0006019737,0.000003799971,0.00013431715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990771,0.00023282417,0.0000905561,0.00024731187,0.00024256289,0.00010969971],"domain_scores_gemma":[0.99880373,0.00038777376,0.00035774705,0.00015182616,0.00019832632,0.000100481586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002379812,0.0003229746,0.00062784477,0.00080391427,0.00022313686,0.0004948416,0.00029831176,0.00032664716,0.00055667356],"category_scores_gemma":[0.0021525607,0.00019847655,0.00039964318,0.00065021886,0.0003574593,0.0001979055,0.00029041298,0.000417345,0.00013791714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006093135,0.00027648802,0.9418532,0.00012390393,0.00032416594,0.00016607033,0.0002384742,0.0014124973,0.027374562,0.00006281686,0.00016430202,0.021910407],"study_design_scores_gemma":[0.00013207099,0.002284312,0.97981787,0.000011250717,0.00023619359,0.0006153818,0.00009053297,0.0032389753,0.012761744,0.00005914556,0.00073606754,0.00001638508],"about_ca_topic_score_codex":0.0024868443,"about_ca_topic_score_gemma":0.0025113523,"teacher_disagreement_score":0.0024868443,"about_ca_system_score_codex":0.0007508411,"about_ca_system_score_gemma":0.00034464794,"threshold_uncertainty_score":0.012585759},"labels":[],"label_agreement":null},{"id":"W4220854540","doi":"10.1158/2767-9764.crc-21-0119","title":"A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Queen's University; Centre hospitalier universitaire de Québec; Canadian Centre for Applied Research in Cancer Control","funders":"National Institute of Environmental Health Sciences; Cancer Research UK; National Institutes of Health; National Cancer Institute; Medical Research Council; National Health and Medical Research Council","keywords":"Genome-wide association study; Breast cancer; Bonferroni correction; Heritability; Biology; Genetic association; Gene–environment interaction; Genetics; Gene; Genotype; Transcriptome; Missing heritability problem; Expression quantitative trait loci; Gene interaction; Population; Cancer; Gene expression; Oncology; Single-nucleotide polymorphism; Medicine","score_opus":0.0649796946101617,"score_gpt":0.3962778853050389,"score_spread":0.3312981906948772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220854540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980258,0.0002140761,0.0003778587,0.000086545726,0.000004766401,0.000011074198,0.0010057755,0.000007103997,0.00026697293],"genre_scores_gemma":[0.99829525,0.000107283995,0.00044503537,0.00006841821,0.0000074442582,0.000022286364,0.0008498242,0.0000060399157,0.0001983407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918264,0.00033844676,0.00004338676,0.00026516494,0.00010347729,0.00006690521],"domain_scores_gemma":[0.99918085,0.0003039117,0.00018172579,0.0001618556,0.000067176945,0.00010438182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009910058,0.00023461583,0.0003768117,0.0004074284,0.000709619,0.0004212475,0.00025246677,0.00035267542,0.0011387613],"category_scores_gemma":[0.00202035,0.0002967004,0.0004478748,0.0012103042,0.00029882014,0.00021785764,0.0005274993,0.0005946386,0.0001870417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019555583,0.0000544748,0.9946202,0.000021185326,0.00039182004,0.00014493582,0.00022104668,0.00009850021,0.0020586338,0.000039672024,0.00020592836,0.0019481173],"study_design_scores_gemma":[0.0000123846785,0.000069309455,0.9987562,0.000003327174,0.00016123017,0.00018059109,0.00010139415,0.00010956893,0.00009958912,0.0000528701,0.0004502594,0.0000032390722],"about_ca_topic_score_codex":0.0059454753,"about_ca_topic_score_gemma":0.010036002,"teacher_disagreement_score":0.0059454753,"about_ca_system_score_codex":0.00024470178,"about_ca_system_score_gemma":0.00035052063,"threshold_uncertainty_score":0.011821747},"labels":[],"label_agreement":null},{"id":"W4224857498","doi":"10.1158/2767-9764.crc-22-0037","title":"Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario","keywords":"Hydroxychloroquine; Repurposing; Itraconazole; Drug repositioning; Ovarian cancer; Cancer; Homeostasis; Medicine; Cancer research; Internal medicine; Pharmacology; Biology; Drug; Coronavirus disease 2019 (COVID-19); Dermatology; Disease; Antifungal","score_opus":0.05911338055807427,"score_gpt":0.4076690462993662,"score_spread":0.34855566574129193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224857498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97648835,0.018166402,0.0018028744,0.0004130543,0.000039632094,0.00022587688,0.00036784267,0.00010613921,0.0023898764],"genre_scores_gemma":[0.99366236,0.003935769,0.0012509256,0.00014076248,0.000011174041,0.000047023168,0.00041641746,0.000009640418,0.0005258842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998815,0.000032498745,0.000010522001,0.000017227741,0.000028686118,0.000029491113],"domain_scores_gemma":[0.9999162,0.000015384097,0.000017684915,0.000015414145,0.000016805521,0.000018569972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028434925,0.00014376277,0.00040474685,0.00027488387,0.000120239165,0.00036367343,0.00019945452,0.00020072551,0.00069390854],"category_scores_gemma":[0.00016376658,0.00009659192,0.0003151745,0.0002446248,0.00014828007,0.00015386257,0.00021659011,0.00046829839,0.0001291643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010626281,0.00048783422,0.0035192114,0.00035260644,0.00008843698,0.00029591858,0.00006930875,0.0019518916,0.92066807,0.00023865691,0.00070265215,0.0705628],"study_design_scores_gemma":[0.001707367,0.019497067,0.05877606,0.00013839363,0.00034187746,0.0035909573,0.00027942422,0.0071446053,0.86712974,0.00074394693,0.040607374,0.000043184296],"about_ca_topic_score_codex":0.00072465517,"about_ca_topic_score_gemma":0.003566735,"teacher_disagreement_score":0.00072465517,"about_ca_system_score_codex":0.00036862513,"about_ca_system_score_gemma":0.00029960604,"threshold_uncertainty_score":0.0026745796},"labels":[],"label_agreement":null},{"id":"W4225528851","doi":"10.1158/2767-9764.crc-21-0106","title":"Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics","year":2021,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Basic Research Laboratory; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"PLK1; Cancer research; Biology; Cancer; Triple-negative breast cancer; Kinase; Gene knockdown; Carboplatin; Breast cancer; Cell cycle; Cell biology; Genetics; Chemotherapy; Cell culture; Cisplatin","score_opus":0.08573933261142894,"score_gpt":0.4397340534195935,"score_spread":0.3539947208081645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225528851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878824,0.0052836393,0.0031007063,0.00074723066,0.000076150965,0.00007951964,0.00060733774,0.00025522648,0.0019677125],"genre_scores_gemma":[0.9957724,0.00087398774,0.0012159308,0.00015559238,0.000016504864,0.000030970266,0.00056632946,0.000019612218,0.0013486135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999856,0.00002306369,0.000015321986,0.000034208504,0.000048819504,0.000022415685],"domain_scores_gemma":[0.9998648,0.000015833286,0.00005580204,0.000010596646,0.0000189679,0.000034049448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038560713,0.00046737125,0.00038068517,0.00044808723,0.00011795867,0.0006015025,0.00022905659,0.0003297193,0.0024272685],"category_scores_gemma":[0.00028701712,0.00012979595,0.00022255997,0.00021290136,0.00024349341,0.00043193056,0.00021359776,0.00085862976,0.00041308312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021103183,0.0001762345,0.020598898,0.0002149298,0.000058503785,0.0003265973,0.000032130247,0.00044675058,0.954294,0.00023701176,0.0005517435,0.020952852],"study_design_scores_gemma":[0.00028976056,0.003964743,0.154099,0.00006029481,0.00027938618,0.0042098965,0.00018046152,0.0060975677,0.81824636,0.00070768245,0.011831422,0.00003337941],"about_ca_topic_score_codex":0.00027950975,"about_ca_topic_score_gemma":0.00055993395,"teacher_disagreement_score":0.0024272685,"about_ca_system_score_codex":0.00053694873,"about_ca_system_score_gemma":0.00023465476,"threshold_uncertainty_score":0.00812006},"labels":[],"label_agreement":null},{"id":"W4281287807","doi":"10.1158/2767-9764.crc-22-0017","title":"The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Fonds de recherche du Québec; Government of Canada","keywords":"KRAS; Ovarian cancer; PTEN; Immunotherapy; Immune system; Cancer research; Cancer; Biology; Tumor microenvironment; Medicine; Immunology; Colorectal cancer; Internal medicine; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.13927708703653421,"score_gpt":0.44566487634236845,"score_spread":0.3063877893058342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281287807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8546643,0.004589506,0.12370876,0.0008060289,0.00032300953,0.0013892581,0.0065632137,0.0008584917,0.007097443],"genre_scores_gemma":[0.885011,0.0042333696,0.096429415,0.00052279845,0.00014105874,0.0024351708,0.0047984477,0.00046416296,0.0059645134],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993326,0.00016290511,0.000088239234,0.00012175446,0.00015931243,0.00013512059],"domain_scores_gemma":[0.9994173,0.00010346507,0.00013777139,0.00013854243,0.000111590576,0.000091373804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095532,0.00081673614,0.0004500439,0.0015263887,0.000401044,0.0007582324,0.0003804626,0.0005746462,0.0012990426],"category_scores_gemma":[0.00043801387,0.0002932842,0.00039401947,0.0005244386,0.00045479665,0.0007206045,0.0004706122,0.002060999,0.00056151353],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015140435,0.00014910683,0.0006126757,0.000068526664,0.000007362646,0.000028250783,0.000041924875,0.00016365112,0.9956405,0.00037269865,0.000105113846,0.002658739],"study_design_scores_gemma":[0.000053470678,0.0012594764,0.005525579,0.000041779047,0.000038347458,0.00043505713,0.00010159442,0.0025917909,0.9806855,0.0004373001,0.008813917,0.00001634145],"about_ca_topic_score_codex":0.0004039372,"about_ca_topic_score_gemma":0.0007051552,"teacher_disagreement_score":0.0015263887,"about_ca_system_score_codex":0.0004124313,"about_ca_system_score_gemma":0.0003264943,"threshold_uncertainty_score":0.0050522685},"labels":[],"label_agreement":null},{"id":"W4281487088","doi":"10.1158/2767-9764.crc-21-0117","title":"Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Mitacs; Government of Canada","keywords":"Ezrin; Chemotherapy; Medicine; Oncology; Metastasis; Breast cancer; Cancer; Internal medicine; Cancer research; Biology; Cell","score_opus":0.1547259839956406,"score_gpt":0.4144323019132961,"score_spread":0.2597063179176555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281487088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939672,0.0028331948,0.0011145876,0.0001798102,0.000036428166,0.000043174616,0.00020830617,0.00007163141,0.0015456738],"genre_scores_gemma":[0.99555737,0.0017952761,0.0008263962,0.00005365248,0.00001013221,0.00002745621,0.00026251358,0.000006488202,0.0014608066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995005,0.0000056957138,0.0000055408664,0.0000093297485,0.000016210113,0.0000132642435],"domain_scores_gemma":[0.9999753,0.0000033467686,0.0000075091243,0.0000030464828,0.000003867523,0.000006992328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006006884,0.00019516321,0.00028692273,0.00011348851,0.00008611225,0.00016449683,0.000101458245,0.0001488663,0.0014067534],"category_scores_gemma":[0.0000560778,0.000049531445,0.00013197413,0.000096833646,0.00011519791,0.0001461509,0.00010888353,0.00041191914,0.00022635038],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001852407,0.00009392207,0.00026883895,0.00007486757,0.000009213,0.000034320732,0.000007726802,0.00012183142,0.994163,0.000044593817,0.00010245379,0.0048939916],"study_design_scores_gemma":[0.00005199829,0.0011227316,0.00830844,0.0000074328677,0.00003834216,0.00029234524,0.000020535688,0.00081065955,0.98571604,0.000033999866,0.0035931675,0.0000043926707],"about_ca_topic_score_codex":0.00030198137,"about_ca_topic_score_gemma":0.0010477189,"teacher_disagreement_score":0.0014067534,"about_ca_system_score_codex":0.0001680394,"about_ca_system_score_gemma":0.00014560758,"threshold_uncertainty_score":0.0047060847},"labels":[],"label_agreement":null},{"id":"W4283361673","doi":"10.1158/2767-9764.crc-22-0082","title":"Prospective Associations of Hemoglobin A1c and c-peptide with Risk of Diabetes-related Cancers in the Cancer Prevention Study-II Nutrition Cohort","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Centers for Disease Control and Prevention; World Health Organization; National Institutes of Health; American Cancer Society","keywords":"Medicine; Internal medicine; Prospective cohort study; Cancer; Cohort; Diabetes mellitus; Colorectal cancer; Type 2 diabetes; Pancreatic cancer; Glycemic; Bladder cancer; Proportional hazards model; Oncology; Gastroenterology; Endocrinology; Insulin","score_opus":0.03793149222811286,"score_gpt":0.373782255448416,"score_spread":0.3358507632203031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283361673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783236,0.00028438063,0.00019073777,0.00004406937,0.000017317645,0.000018232404,0.0012887301,0.000008164105,0.0003158741],"genre_scores_gemma":[0.9976017,0.00019016884,0.00021234542,0.00004316668,0.000015632788,0.000030050996,0.0014250352,0.0000064809733,0.0004755398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947685,0.00014531569,0.000040810155,0.00018145156,0.0000718797,0.00008366053],"domain_scores_gemma":[0.9987041,0.00018797553,0.00034279638,0.00031331723,0.00016222164,0.00028963294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012934481,0.00044274953,0.00054467074,0.00058992836,0.0005486073,0.0008287837,0.00045573016,0.00059500796,0.0010734121],"category_scores_gemma":[0.0018853508,0.00078197615,0.0009124607,0.00095517345,0.00017426231,0.000324933,0.0005584887,0.0011075594,0.00020111803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000482588,0.00006363112,0.99799466,0.000006814281,0.00023915882,0.00005805599,0.000041344956,0.000055082273,0.00033912656,0.000017054777,0.00019015161,0.00051232765],"study_design_scores_gemma":[0.000047950027,0.0001099843,0.99901867,0.000004855841,0.00015608086,0.000117922355,0.00005635563,0.00023393761,0.000056915353,0.000019579418,0.00017261623,0.000005178588],"about_ca_topic_score_codex":0.0158416,"about_ca_topic_score_gemma":0.013730428,"teacher_disagreement_score":0.0158416,"about_ca_system_score_codex":0.00024727412,"about_ca_system_score_gemma":0.00044814427,"threshold_uncertainty_score":0.03149879},"labels":[],"label_agreement":null},{"id":"W4292185501","doi":"10.1158/2767-9764.crc-21-0135","title":"Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation; National Institute of Dental and Craniofacial Research; Free To Breathe; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; North Carolina Biotechnology Center; Lung Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Yale University","keywords":"Immunohistochemistry; Tissue microarray; Head and neck squamous-cell carcinoma; Immunostaining; Medicine; Cancer; Head and neck cancer; Cancer research; Pathology; Oncology; Immune system; HPV infection; Biomarker; Biology; Internal medicine; Cervical cancer; Immunology","score_opus":0.13157024526347763,"score_gpt":0.4713348231637256,"score_spread":0.33976457790024794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292185501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979286,0.001257825,0.00039332605,0.00003974902,0.000004828638,0.000007768846,0.000111428504,0.000012844846,0.00024356751],"genre_scores_gemma":[0.9991748,0.00021158902,0.00036899792,0.00001293718,0.000004760966,0.000005446286,0.0001348089,0.0000017544104,0.00008490987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997242,0.00008777718,0.000019872814,0.00005945002,0.0000670742,0.000041532065],"domain_scores_gemma":[0.9995838,0.00010196486,0.00013861574,0.000035741457,0.00008331118,0.00005663326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008185585,0.00021855357,0.000280405,0.00071163574,0.00017627171,0.0004560387,0.0002495162,0.0003154429,0.0003912335],"category_scores_gemma":[0.0009997269,0.00013560132,0.00022487645,0.00055829075,0.00028560805,0.00025715033,0.00043193073,0.00031295398,0.00012354882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006783445,0.000033082844,0.9693944,0.000041063213,0.0000970781,0.00009342464,0.000039478848,0.00036958867,0.018672435,0.000030871615,0.00015792805,0.010392274],"study_design_scores_gemma":[0.000009941196,0.00020743441,0.98770183,0.000009292904,0.000106743566,0.00049150153,0.00011376901,0.0040217615,0.0067675347,0.00012909963,0.00043235102,0.000008754353],"about_ca_topic_score_codex":0.0011980919,"about_ca_topic_score_gemma":0.0021225489,"teacher_disagreement_score":0.0011980919,"about_ca_system_score_codex":0.0003531848,"about_ca_system_score_gemma":0.00018897287,"threshold_uncertainty_score":0.0043290257},"labels":[],"label_agreement":null},{"id":"W4293244159","doi":"10.1158/2767-9764.crc-22-0083","title":"Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"ZonMw; Auris Health","keywords":"Chronic lymphocytic leukemia; B cell; Cancer research; Cell culture; T cell; CD19; Antigen; Antibody; Medicine; Leukemia; Immunology; Biology; Immune system","score_opus":0.1152114811457825,"score_gpt":0.40627376921070274,"score_spread":0.29106228806492024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293244159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98259926,0.011521414,0.0033751554,0.00007670449,0.00003334515,0.00007518661,0.00012672461,0.00012457684,0.0020677196],"genre_scores_gemma":[0.9919465,0.0038490759,0.0021342793,0.000080872866,0.000015599917,0.00009535216,0.00028050583,0.000014142845,0.0015836691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999105,0.000019229079,0.000008441906,0.000015121055,0.000022009861,0.00002461661],"domain_scores_gemma":[0.99996793,0.0000069482708,0.0000069909825,0.0000045855636,0.00000473708,0.000008757759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018384767,0.0002670412,0.0002406906,0.00024348461,0.00011610686,0.00027742248,0.0001603951,0.00022120072,0.0006890686],"category_scores_gemma":[0.000088829416,0.00009802254,0.00019821142,0.00020068281,0.0001316412,0.00014526046,0.00016127354,0.00039103173,0.00025197907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000255436,0.000082961065,0.0004584865,0.000103355866,0.000010443669,0.00009027746,0.000020107274,0.00014218509,0.99040514,0.00007992887,0.000113111884,0.008238539],"study_design_scores_gemma":[0.00016394418,0.0018104778,0.00938742,0.000019005607,0.00006148657,0.0013732428,0.000033194203,0.0019349629,0.9731713,0.00008916755,0.0119475825,0.000008249083],"about_ca_topic_score_codex":0.0006830485,"about_ca_topic_score_gemma":0.0013480751,"teacher_disagreement_score":0.0006890686,"about_ca_system_score_codex":0.0003540701,"about_ca_system_score_gemma":0.00019650708,"threshold_uncertainty_score":0.0025689602},"labels":[],"label_agreement":null},{"id":"W4295280957","doi":"10.1158/2767-9764.crc-22-0190","title":"Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"Cancer Research Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Meath Foundation","keywords":"Meta-analysis; Pancreatic cancer; Medicine; Systematic review; Internal medicine; Oncology; Cancer; MEDLINE; Biology","score_opus":0.5081880451646883,"score_gpt":0.5801279835435706,"score_spread":0.07193993837888235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295280957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002878584,0.9954276,0.00045005226,0.00019182316,0.000093235605,0.00017069925,0.000592928,0.000019279985,0.00017566877],"genre_scores_gemma":[0.13830161,0.85519195,0.0024337799,0.0009996436,0.00029634652,0.0010094912,0.0014578336,0.00003927279,0.00027004164],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9873182,0.005780895,0.0037001944,0.0014034553,0.0014230923,0.00037415835],"domain_scores_gemma":[0.96320343,0.029084925,0.0039697858,0.0009364497,0.0024999718,0.0003055378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016926304,0.0028309303,0.018220788,0.008210901,0.0007191645,0.0034499888,0.0022678992,0.0021507884,0.003029292],"category_scores_gemma":[0.04847044,0.0014587374,0.03664139,0.009118349,0.0007840011,0.0020371354,0.0016217313,0.0018109385,0.00038794792],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001210716,0.000016958693,0.0070213242,0.4513906,0.5271911,0.0001406253,0.000092846734,0.000507949,0.00020626411,0.00012409098,0.0007378385,0.011359733],"study_design_scores_gemma":[0.00022156742,0.00010740061,0.0043145292,0.0318708,0.96131736,0.0001037266,0.000036635676,0.00017061112,0.00009656412,0.00014922008,0.0015893177,0.000022280901],"about_ca_topic_score_codex":0.008120675,"about_ca_topic_score_gemma":0.018355241,"teacher_disagreement_score":0.018220788,"about_ca_system_score_codex":0.00267627,"about_ca_system_score_gemma":0.0045299106,"threshold_uncertainty_score":0.089515924},"labels":[],"label_agreement":null},{"id":"W4307638653","doi":"10.1158/2767-9764.crc-22-0240","title":"<i>Ad hoc</i> Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline <i>BRCA</i> Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Homologous recombination; Germline; Ovarian cancer; Medicine; Oncology; Biology; Cancer; Genetics; Internal medicine; DNA; Gene","score_opus":0.15425510176700669,"score_gpt":0.47739420077474237,"score_spread":0.3231390990077357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307638653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97288877,0.005054037,0.002619321,0.00057758973,0.0002650524,0.0038335517,0.0078148795,0.00013807333,0.0068087378],"genre_scores_gemma":[0.9779027,0.0011704447,0.0030878366,0.0013943365,0.00028958052,0.0036150874,0.009357567,0.00009876366,0.0030836726],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99520737,0.003365871,0.00020576794,0.0005290208,0.00039564547,0.00029631148],"domain_scores_gemma":[0.994991,0.002341789,0.0011699233,0.0007100074,0.00035583397,0.0004314737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009286215,0.0014148443,0.0023502312,0.00039369887,0.00027677655,0.0016680134,0.0009469327,0.0007461054,0.0025296551],"category_scores_gemma":[0.005867007,0.00042131677,0.005130435,0.000565856,0.00074129354,0.0006685663,0.00054256077,0.0016750324,0.00044851415],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8243974,0.0027812188,0.067263566,0.0022404322,0.032425925,0.00039717986,0.00016879356,0.0048852074,0.022297932,0.0008258322,0.0071496195,0.035166886],"study_design_scores_gemma":[0.32548365,0.25099063,0.29107296,0.00036241038,0.04935688,0.0013286095,0.0002776485,0.011732863,0.02842868,0.0026118446,0.038138058,0.00021575377],"about_ca_topic_score_codex":0.00059375627,"about_ca_topic_score_gemma":0.0016215097,"teacher_disagreement_score":0.009286215,"about_ca_system_score_codex":0.000993688,"about_ca_system_score_gemma":0.001958831,"threshold_uncertainty_score":0.04911077},"labels":[],"label_agreement":null},{"id":"W4312070075","doi":"10.1158/2767-9764.crc-22-0410","title":"Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Rogel Cancer Center, University of Michigan","keywords":"Pacific islanders; Incidence (geometry); Medicine; Ovarian cancer; Demography; Epidemiology; Ethnic group; Serous fluid; Confidence interval; Cancer; Gynecology; Oncology; Internal medicine; Population; Environmental health","score_opus":0.1301284505922743,"score_gpt":0.45416079050489827,"score_spread":0.324032339912624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312070075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623443,0.0029362915,0.00046199522,0.00089905574,0.00007189048,0.000038685703,0.029572213,0.00008783058,0.0035876834],"genre_scores_gemma":[0.96997225,0.0015890377,0.0004006091,0.00041099254,0.00006442087,0.00006285317,0.026163062,0.000015780586,0.0013210825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996182,0.000077863246,0.000054735483,0.000093559116,0.00008358001,0.00007210423],"domain_scores_gemma":[0.99844223,0.00019368264,0.00065788225,0.00007767188,0.0004913529,0.00013726063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060879556,0.00018009926,0.00021920659,0.0014442916,0.00026363743,0.00046205998,0.00037007598,0.0003147448,0.0012601143],"category_scores_gemma":[0.0018312339,0.00021115488,0.00045882587,0.0020101767,0.00014813337,0.00044578282,0.00035488486,0.0005086416,0.00035555114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013161809,0.000036071822,0.98726636,0.000071934,0.00011880424,0.000059996986,0.00009572736,0.0003677105,0.00025299552,0.000092211325,0.00430683,0.0071998104],"study_design_scores_gemma":[0.0000066025227,0.000026613343,0.9972191,0.000019606932,0.000035011584,0.000099631674,0.00011622901,0.00036005277,0.00007315749,0.000016622183,0.0020228059,0.0000045191946],"about_ca_topic_score_codex":0.096666835,"about_ca_topic_score_gemma":0.13074091,"teacher_disagreement_score":0.096666835,"about_ca_system_score_codex":0.0011066915,"about_ca_system_score_gemma":0.0008061262,"threshold_uncertainty_score":0.19220835},"labels":[],"label_agreement":null},{"id":"W4318483914","doi":"10.1158/2767-9764.crc-22-0456","title":"Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Epigenomics; Melanoma; DNA sequencing; Cell-free fetal DNA; CDKN2A; Oncology; Computational biology; Medicine; Biology; Cancer research; Internal medicine; DNA; Cancer; Gene; DNA methylation; Genetics","score_opus":0.09865593293251709,"score_gpt":0.4082315612715743,"score_spread":0.30957562833905716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318483914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987683,0.00075629714,0.010780091,0.00004176739,0.0000053064928,0.000017702927,0.00049700437,0.00005731007,0.00016152913],"genre_scores_gemma":[0.9932941,0.00015324297,0.0057937996,0.000032001248,0.00000564301,0.000018396726,0.0005135874,0.0000106250645,0.00017857309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996481,0.000093004484,0.000020874655,0.00012580973,0.00007652311,0.00003567912],"domain_scores_gemma":[0.9990264,0.00031545505,0.00030520532,0.000102146885,0.00015949298,0.000091290174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009344946,0.00021199005,0.00030218586,0.0007357657,0.00017978219,0.0004579801,0.00019700613,0.00027442013,0.000605325],"category_scores_gemma":[0.0019430242,0.00013667344,0.00023712649,0.00059962703,0.00022461182,0.00027653837,0.00037514308,0.00038525584,0.00019651983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009337494,0.00013700857,0.6345066,0.00012324005,0.00025321002,0.00021267265,0.00030436376,0.0029145128,0.32074028,0.00022013759,0.0001568751,0.039497416],"study_design_scores_gemma":[0.000030231133,0.0010220562,0.8205717,0.00003350046,0.00028166545,0.0015689781,0.00023515947,0.023870131,0.14972842,0.0006582486,0.0019537013,0.000046286616],"about_ca_topic_score_codex":0.0014774153,"about_ca_topic_score_gemma":0.0023727594,"teacher_disagreement_score":0.0014774153,"about_ca_system_score_codex":0.00029921555,"about_ca_system_score_gemma":0.00023604058,"threshold_uncertainty_score":0.0049421787},"labels":[],"label_agreement":null},{"id":"W4320915582","doi":"10.1158/2767-9764.crc-22-0278","title":"Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Canada's Michael Smith Genome Sciences Centre; iCo Therapeutics (Canada); University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Government of Canada","keywords":"Immune system; Cancer research; Immunotherapy; Medicine; Myeloid; Tumor microenvironment; Cancer immunotherapy; Immunology; T cell; Adoptive cell transfer; Myeloid-derived Suppressor Cell; Dendritic cell; Immune tolerance; Progenitor cell; Cancer; Biology; Stem cell; Suppressor; Cell biology; Internal medicine","score_opus":0.07868338862103307,"score_gpt":0.3562744120607587,"score_spread":0.27759102343972564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320915582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826694,0.0003962701,0.00043308406,0.000034303575,0.0000058092014,0.000013569286,0.00035541126,0.000035306017,0.00045917445],"genre_scores_gemma":[0.9979517,0.0003176932,0.00039949993,0.000023153852,0.000003016166,0.00002256247,0.00041252808,0.000008741268,0.00086119707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99992216,0.000008287206,0.0000051042944,0.000019153858,0.00002331657,0.00002192134],"domain_scores_gemma":[0.9999596,0.0000045926195,0.000011504068,0.00000550922,0.0000043158857,0.000014490243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058043206,0.00019967201,0.00014546006,0.00021811848,0.00006108908,0.00016837653,0.00008112445,0.0001571017,0.00065597106],"category_scores_gemma":[0.00005519518,0.000069000525,0.0001118705,0.00012025751,0.00013345055,0.00007817742,0.00008904262,0.00034189914,0.000147657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112255846,0.000017741631,0.00035791344,0.000008044064,0.0000025480267,0.000014346716,0.000007589908,0.000056842448,0.99843675,0.00002541187,0.000018677378,0.00094186596],"study_design_scores_gemma":[0.000015701582,0.0004638167,0.011766438,0.0000028785387,0.000015449708,0.00021949009,0.00002893129,0.0006888549,0.98542595,0.000032062613,0.0013373554,0.0000029680132],"about_ca_topic_score_codex":0.0010050127,"about_ca_topic_score_gemma":0.0015572988,"teacher_disagreement_score":0.0010050127,"about_ca_system_score_codex":0.0002933986,"about_ca_system_score_gemma":0.00019044291,"threshold_uncertainty_score":0.0021944642},"labels":[],"label_agreement":null},{"id":"W4323353330","doi":"10.1158/2767-9764.crc-22-0385","title":"Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer","year":2023,"lang":"en","type":"review","venue":"Cancer Research Communications","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation; Michael Smith Health Research BC","keywords":"Medicine; Colorectal cancer; Radiation therapy; Chemoradiotherapy; Internal medicine; Stage (stratigraphy); Multivariate analysis; Confidence interval; Oncology; Cancer; Young adult; Surgery","score_opus":0.21903878581119057,"score_gpt":0.5103444049152507,"score_spread":0.2913056191040601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323353330","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790996,0.0011329565,0.00004396709,0.0001076536,0.000006607443,0.0000051096213,0.00031925587,0.000002273567,0.00047216206],"genre_scores_gemma":[0.9991861,0.00034180353,0.000040026538,0.000038829217,0.000004905405,0.0000025200895,0.00028133346,0.0000016609772,0.00010280975],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962187,0.000051448456,0.000044341952,0.00006520935,0.00010415616,0.0001130294],"domain_scores_gemma":[0.99888843,0.00014844834,0.0005391893,0.000039642193,0.00016636813,0.00021790796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024548438,0.000122414,0.00024088412,0.00046798243,0.0003992477,0.00042953633,0.00031529408,0.00027838824,0.00057839236],"category_scores_gemma":[0.0015844904,0.00013467699,0.0002853865,0.0010598262,0.00025197738,0.00019151218,0.0002538658,0.00042357296,0.00008367187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006592377,0.000007990585,0.99772996,0.000010414434,0.000021023216,0.000098549186,0.000057108777,0.000046109813,0.0001300739,0.000007243207,0.00012927204,0.0016963582],"study_design_scores_gemma":[0.0000019926777,0.000017115712,0.9992762,0.000012110437,0.00001010669,0.00021969204,0.00017350602,0.0000723538,0.000034781613,0.000009646153,0.0001696111,0.0000027353083],"about_ca_topic_score_codex":0.20524743,"about_ca_topic_score_gemma":0.44047543,"teacher_disagreement_score":0.20524743,"about_ca_system_score_codex":0.0019481666,"about_ca_system_score_gemma":0.0016762775,"threshold_uncertainty_score":0.4081055},"labels":[],"label_agreement":null},{"id":"W4361269370","doi":"10.1158/2767-9764.crc-22-0403","title":"CD142 Identifies Neoplastic Desmoid Tumor Cells, Uncovering Interactions Between Neoplastic and Stromal Cells That Drive Proliferation","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Hospital for Sick Children; Desmoid Tumor Research Foundation","keywords":"Stromal cell; Cancer research; Tumor cells; Biology; Cell biology; Pathology; Medicine","score_opus":0.16229349146834116,"score_gpt":0.433191921041039,"score_spread":0.27089842957269783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361269370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336845,0.00042803743,0.0050177025,0.00004672241,0.000005836946,0.00003316023,0.00025278813,0.00005484723,0.0007925799],"genre_scores_gemma":[0.9838864,0.000436892,0.012445295,0.000053753367,0.000005469718,0.000039733986,0.0009299634,0.000022409788,0.00218],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99992037,0.000010025866,0.000006039861,0.000019031559,0.000029799749,0.000014671021],"domain_scores_gemma":[0.9999454,0.000010998154,0.000013004056,0.000005497134,0.000011011083,0.0000141927785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096536765,0.00019289546,0.00011506299,0.00048639817,0.00012770876,0.00023612389,0.00010902855,0.00026521867,0.001029264],"category_scores_gemma":[0.00012269833,0.000104659084,0.00013773184,0.00017353852,0.000101230085,0.000111819936,0.00015550507,0.00022445105,0.00031226373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028444218,0.0000063343246,0.0014180591,0.000008257043,0.0000022625634,0.000025011797,0.0000048264933,0.000023243098,0.99764144,0.000023516475,0.000013543183,0.0008051732],"study_design_scores_gemma":[0.000009384431,0.000117495685,0.03372337,0.0000038352873,0.000015374453,0.00068809366,0.0000462036,0.0032826923,0.9605445,0.00007403621,0.0014921741,0.0000028520221],"about_ca_topic_score_codex":0.00037414092,"about_ca_topic_score_gemma":0.0009118588,"teacher_disagreement_score":0.001029264,"about_ca_system_score_codex":0.00019193519,"about_ca_system_score_gemma":0.00011356982,"threshold_uncertainty_score":0.0034431815},"labels":[],"label_agreement":null},{"id":"W4362577044","doi":"10.1158/2767-9764.crc-22-0402","title":"Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital; McMaster University; London Health Sciences Centre; Western University; Ontario Brain Institute; Vector Institute; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Government of Canada; Robert Connor Dawes Foundation; Hospital for Sick Children; Terry Fox Research Institute; Garron Family Cancer Centre","keywords":"Penetrance; Li–Fraumeni syndrome; Germline; Cancer; Genetics; Biology; Epigenetics; Germline mutation; Breast cancer; Genetic testing; Bioinformatics; Oncology; Gene; Medicine; Phenotype; Mutation","score_opus":0.09316922365304761,"score_gpt":0.4119469256300037,"score_spread":0.3187777019769561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362577044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928075,0.00017474279,0.00031109346,0.000035128796,0.000002014162,0.0000030353651,0.0000747175,0.000018351304,0.000100157034],"genre_scores_gemma":[0.99961996,0.0000460401,0.00020588707,0.0000072133475,0.0000031089205,0.0000017904385,0.000087019085,0.000002411443,0.000026552918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995536,0.00009641403,0.000053910033,0.00014628589,0.00008957221,0.000060141105],"domain_scores_gemma":[0.99802715,0.00072743744,0.0008238294,0.00013774518,0.0001291299,0.00015482766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077498995,0.0003854059,0.0003858114,0.0011118365,0.00037001073,0.0005646852,0.0002858088,0.00040878248,0.00071751024],"category_scores_gemma":[0.004340964,0.00023949952,0.00047957918,0.00094865024,0.00034624353,0.00031920997,0.00048024298,0.00054893864,0.00012264546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008576348,0.000009016149,0.9960312,0.0000036655265,0.00003550818,0.00027905012,0.00002970681,0.00048757376,0.000831008,0.000017167557,0.000040383,0.0021499442],"study_design_scores_gemma":[0.000015378722,0.00011068245,0.98605114,0.00000709914,0.00009985795,0.0034596813,0.0001193124,0.008367334,0.0012709614,0.00023988464,0.00024514162,0.000013604395],"about_ca_topic_score_codex":0.004126913,"about_ca_topic_score_gemma":0.004557833,"teacher_disagreement_score":0.004126913,"about_ca_system_score_codex":0.00037762875,"about_ca_system_score_gemma":0.00029883496,"threshold_uncertainty_score":0.008205771},"labels":[],"label_agreement":null},{"id":"W4376956889","doi":"10.1158/2767-9764.crc-23-0010","title":"Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; National Institutes of Health; MPN Research Foundation; Northwestern University; National Institute of General Medical Sciences; Robert H. Lurie Comprehensive Cancer Center; Weinberg College of Arts and Sciences, Northwestern University; U.S. Department of Veterans Affairs","keywords":"Myeloproliferative neoplasm; Neoplasm; Cancer research; Myeloproliferative Disorders; Immunology; Medicine; Myelofibrosis; Bone marrow; Pathology","score_opus":0.16180218825012613,"score_gpt":0.4612231435675354,"score_spread":0.2994209553174093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376956889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871976,0.004826331,0.0028199567,0.00031474285,0.00007440257,0.000049379552,0.00025068037,0.00012105015,0.0028237528],"genre_scores_gemma":[0.99523443,0.0013686481,0.0015258061,0.00008653501,0.000017854323,0.000029761137,0.00020297241,0.0000116858355,0.0015223447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999485,0.000008942436,0.0000036912393,0.000010361859,0.000012847141,0.00001558301],"domain_scores_gemma":[0.9999614,0.000010953842,0.0000079751035,0.0000041219278,0.0000041913454,0.000011350961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009262441,0.00021426352,0.00021098422,0.00014849033,0.00010436608,0.00017974773,0.0001023583,0.00020200651,0.0014169755],"category_scores_gemma":[0.00006716285,0.0000538286,0.00010594103,0.00007604386,0.00015347428,0.00011572617,0.00010693813,0.00046082266,0.00028453802],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017733987,0.00006937183,0.00011858283,0.000044435583,0.000003828678,0.000017762717,0.000010181901,0.00007681545,0.9954852,0.00009147707,0.00009281958,0.0038123573],"study_design_scores_gemma":[0.000051762985,0.0006607927,0.002165777,0.000006315471,0.00001241762,0.00014598145,0.000012065301,0.00066898885,0.9926394,0.000036851397,0.0035977764,0.0000018819294],"about_ca_topic_score_codex":0.00025565227,"about_ca_topic_score_gemma":0.00054245425,"teacher_disagreement_score":0.0014169755,"about_ca_system_score_codex":0.00017617359,"about_ca_system_score_gemma":0.00015445054,"threshold_uncertainty_score":0.004740298},"labels":[],"label_agreement":null},{"id":"W4378212723","doi":"10.1158/2767-9764.crc-23-0144","title":"Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Metabolomics Innovation Centre","funders":"Société d'Accélération du Transfert de Technologies; Région Occitanie Pyrénées-Méditerranée; Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Stem cell; Mesenchymal stem cell; Glioblastoma; Cancer stem cell; Cell biology; Mitochondrion; Cancer research; Biology; Neural stem cell; Chemistry","score_opus":0.08613808428419077,"score_gpt":0.37143782093573,"score_spread":0.28529973665153924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378212723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036306,0.0012974032,0.005887532,0.0002496965,0.00005905115,0.00004493189,0.00055796036,0.0002898539,0.001250442],"genre_scores_gemma":[0.99586296,0.00068421115,0.0016366683,0.00007078445,0.000009413065,0.000027220052,0.00041948844,0.00003119458,0.0012580154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998398,0.000022673406,0.000016378595,0.00003415895,0.000057133344,0.00002992727],"domain_scores_gemma":[0.9999201,0.0000100955485,0.000031861913,0.0000099874715,0.000012007446,0.000015943566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001099515,0.00029635607,0.00027369088,0.00025337056,0.0001171212,0.00033733368,0.00014398212,0.00029915222,0.0013079242],"category_scores_gemma":[0.00009610058,0.00008599811,0.00024644093,0.00015458534,0.00023824623,0.00022126632,0.00027422502,0.00049244397,0.00031622217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059739705,0.000017036047,0.00013505384,0.00003852916,0.000005778225,0.000032444714,0.0000149374755,0.000056526333,0.9978411,0.0001061791,0.00003303746,0.0016595328],"study_design_scores_gemma":[0.000011488943,0.0003325084,0.0026187156,0.000007221378,0.000020267677,0.00015670138,0.000040166982,0.0006354455,0.99363744,0.000077386314,0.0024580765,0.0000046501805],"about_ca_topic_score_codex":0.0003535941,"about_ca_topic_score_gemma":0.0004034658,"teacher_disagreement_score":0.0013079242,"about_ca_system_score_codex":0.00021445073,"about_ca_system_score_gemma":0.000161116,"threshold_uncertainty_score":0.0043754578},"labels":[],"label_agreement":null},{"id":"W4378233411","doi":"10.1158/2767-9764.crc-23-0003","title":"Antidepressant Use and Lung Cancer Risk and Survival: A Meta-analysis of Observational Studies","year":2023,"lang":"en","type":"review","venue":"Cancer Research Communications","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Central Florida","keywords":"Medicine; Meta-analysis; Lung cancer; Internal medicine; Subgroup analysis; Observational study; Relative risk; Oncology; Cancer; Confidence interval; Cochrane Library","score_opus":0.8016094916276023,"score_gpt":0.6075673273531814,"score_spread":0.1940421642744209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378233411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021545155,0.97401106,0.0022645202,0.00031752972,0.00026953462,0.00028994743,0.00097553316,0.000051960425,0.0002748449],"genre_scores_gemma":[0.46207628,0.52551126,0.006866585,0.00095648126,0.00045485035,0.0014358445,0.002170334,0.0000728532,0.00045550798],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98351973,0.009901256,0.0035779919,0.0015008536,0.0011249952,0.00037528947],"domain_scores_gemma":[0.97000575,0.0222757,0.003972218,0.0017346288,0.0016670072,0.0003446155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022202125,0.0031522256,0.014518464,0.005829005,0.0006868201,0.0033538088,0.0023051756,0.0021394254,0.0022317255],"category_scores_gemma":[0.043337222,0.0019687198,0.06540776,0.007406087,0.0005754481,0.0014054326,0.0016526553,0.0025404827,0.00028557755],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021845917,0.000020601867,0.0081147,0.042104725,0.9426779,0.00008604831,0.000038333375,0.00075988955,0.00010908088,0.000060259266,0.00024097154,0.0036027622],"study_design_scores_gemma":[0.00034983206,0.000120478566,0.0039492273,0.0028501195,0.9916614,0.000058569534,0.000019970543,0.00035869482,0.000059454946,0.00014060999,0.00041802725,0.000013596458],"about_ca_topic_score_codex":0.007714784,"about_ca_topic_score_gemma":0.010596438,"teacher_disagreement_score":0.022202125,"about_ca_system_score_codex":0.0024213158,"about_ca_system_score_gemma":0.0023704288,"threshold_uncertainty_score":0.117417455},"labels":[],"label_agreement":null},{"id":"W4379798163","doi":"10.1158/2767-9764.crc-22-0152","title":"Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sciencetech (Canada); Princess Margaret Cancer Centre; Artificial Intelligence in Medicine (Canada); University of Toronto","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Generalizability theory; Radiomics; Artificial intelligence; Machine learning; Computer science; Deep learning; Artificial neural network; Medicine; Medical physics; Statistics","score_opus":0.22343244065220885,"score_gpt":0.5324583583627135,"score_spread":0.30902591771050464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379798163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96463656,0.0010410496,0.028959317,0.0018251613,0.00012031455,0.00018892103,0.0011806636,0.00056190783,0.001486152],"genre_scores_gemma":[0.99308866,0.000153634,0.005335224,0.00015875108,0.0000357841,0.000052142976,0.0009493805,0.000027669166,0.00019874965],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967907,0.0019266144,0.0001656659,0.0006603949,0.0002550129,0.00020158163],"domain_scores_gemma":[0.9863197,0.009205757,0.0010463278,0.0018739353,0.0010178039,0.00053646776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018238364,0.0011246937,0.00085323467,0.0013327289,0.0004926001,0.0013054382,0.0017931749,0.0012644009,0.00083672674],"category_scores_gemma":[0.029320536,0.00043091536,0.0016843885,0.0010036937,0.000969613,0.001975936,0.00300557,0.0017123951,0.00024125165],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001589697,0.0006671838,0.26780125,0.0002185429,0.0010784696,0.00016286438,0.00029376853,0.6382998,0.0008037391,0.0012994778,0.0019260015,0.085859284],"study_design_scores_gemma":[0.000046231857,0.00039219426,0.020936055,0.000045759654,0.00012049625,0.00005102074,0.00012467885,0.97477436,0.0007860119,0.0021581035,0.00053193234,0.000033137578],"about_ca_topic_score_codex":0.020635564,"about_ca_topic_score_gemma":0.012037363,"teacher_disagreement_score":0.020635564,"about_ca_system_score_codex":0.001770694,"about_ca_system_score_gemma":0.0015988088,"threshold_uncertainty_score":0.09645486},"labels":[],"label_agreement":null},{"id":"W4383556694","doi":"10.1158/2767-9764.crc-23-0111","title":"Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Astellas Pharma; Academy of Medical Sciences; China Scholarship Council; National Institute for Health and Care Research; Wilhelm Sander-Stiftung; Medical Research Council; Sanofi; Prostate Cancer UK; Prostate Cancer Foundation","keywords":"Fulvestrant; Estrogen receptor; Cancer research; Breast cancer; Estrogen receptor alpha; Androgen receptor; Imidazopyridine; Prostate cancer; Cancer; Pharmacology; Transactivation; Estrogen; Cell growth; Chemistry; Internal medicine; Biology; Medicine; Biochemistry; Gene expression","score_opus":0.08932779712755888,"score_gpt":0.45344929119679017,"score_spread":0.3641214940692313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383556694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9463648,0.023248304,0.014533652,0.0004979207,0.00018543379,0.0006365895,0.00097036094,0.0004434532,0.013119466],"genre_scores_gemma":[0.97217166,0.010230096,0.009578409,0.00019323174,0.000038491784,0.00017722034,0.0007337667,0.000020819349,0.0068562417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995196,0.000006227031,0.000003133705,0.000011463119,0.000013538633,0.000013612195],"domain_scores_gemma":[0.99996686,0.000004026927,0.0000106218995,0.0000028100576,0.000006633185,0.000009070752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009289331,0.00041734718,0.00031619897,0.00023648032,0.000091362,0.00022133786,0.00029069054,0.0002647374,0.0013887018],"category_scores_gemma":[0.000081814556,0.000125487,0.00025776005,0.0001475226,0.000119956065,0.00014085165,0.00014801958,0.00043648685,0.00044985692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025353098,0.00020623601,0.00018874236,0.0002791137,0.000023654446,0.00025617113,0.000033434713,0.000779846,0.9706078,0.00061715674,0.00044498913,0.026309347],"study_design_scores_gemma":[0.0007005675,0.010634043,0.00459775,0.000060586724,0.0001446729,0.0015133118,0.000033274417,0.0035995916,0.9440713,0.00024271813,0.034361277,0.000040757932],"about_ca_topic_score_codex":0.0004526549,"about_ca_topic_score_gemma":0.00086909195,"teacher_disagreement_score":0.0013887018,"about_ca_system_score_codex":0.00029766004,"about_ca_system_score_gemma":0.00018903613,"threshold_uncertainty_score":0.0046456456},"labels":[],"label_agreement":null},{"id":"W4385553990","doi":"10.1158/2767-9764.crc-23-0284","title":"Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sanofi","keywords":"Medicine; Dosing; Pharmacokinetics; Adverse effect; Internal medicine; Gastroenterology; Surgery","score_opus":0.17965015765821107,"score_gpt":0.5281509426034129,"score_spread":0.3485007849452018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385553990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982975,0.00092260295,0.0001981039,0.000052568957,0.000016875983,0.00014551872,0.00008722238,0.000015474227,0.00026412503],"genre_scores_gemma":[0.997546,0.0006325166,0.0007086975,0.00010758294,0.00004101845,0.0002458236,0.00037914963,0.0000075701014,0.00033156876],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99956006,0.00019680952,0.000026076867,0.00008130317,0.000060197268,0.0000755932],"domain_scores_gemma":[0.9995858,0.00008360641,0.00011475901,0.000053824024,0.000022947732,0.00013904924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013722021,0.0007188654,0.0012952806,0.0003137534,0.0002603187,0.00059855095,0.00043569953,0.00056555937,0.0012165003],"category_scores_gemma":[0.0006846792,0.0003455988,0.00085845107,0.00041338959,0.00058796676,0.00066014857,0.0002502879,0.0020573118,0.00025924225],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40241787,0.07865514,0.030591328,0.0009578112,0.0018136956,0.0005007313,0.00072316726,0.007998911,0.22129743,0.00051452324,0.0018757245,0.25265366],"study_design_scores_gemma":[0.1034698,0.8385572,0.03438239,0.00003379786,0.0005111476,0.0006471508,0.000096117015,0.0033320128,0.0155357,0.00017512165,0.0032232848,0.000036258047],"about_ca_topic_score_codex":0.00059392833,"about_ca_topic_score_gemma":0.0014358864,"teacher_disagreement_score":0.0013722021,"about_ca_system_score_codex":0.0007485489,"about_ca_system_score_gemma":0.0007903011,"threshold_uncertainty_score":0.0072569847},"labels":[],"label_agreement":null},{"id":"W4386878679","doi":"10.1158/2767-9764.crc-23-0084","title":"The Inherited <i>KRAS</i> -variant as a Biomarker of Cetuximab Response in NSCLC","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"University of Texas MD Anderson Cancer Center; National Cancer Institute; NRG Oncology; Eli Lilly and Company","keywords":"Cetuximab; KRAS; Medicine; Internal medicine; Hazard ratio; Oncology; Lung cancer; Proportional hazards model; Confidence interval; Log-rank test; Colorectal cancer; Cancer","score_opus":0.16787399247325435,"score_gpt":0.5265000442890272,"score_spread":0.35862605181577284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386878679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693066,0.0022840574,0.00016271953,0.000118776086,0.000023091678,0.000050531424,0.00017536315,0.000009990295,0.0002447723],"genre_scores_gemma":[0.99909925,0.00024309767,0.00025170005,0.000054663156,0.000029188794,0.000021314243,0.00018057835,0.0000028887675,0.00011742437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999071,0.00055074546,0.000056813507,0.000109394925,0.00014605735,0.00006600395],"domain_scores_gemma":[0.9972531,0.00067350053,0.0015588135,0.000106507076,0.00012507518,0.00028308187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025158776,0.0005322881,0.0007231481,0.0003610811,0.00013020477,0.00060201116,0.0003463421,0.00046650754,0.00094253157],"category_scores_gemma":[0.002929462,0.00019212652,0.0006030546,0.00041433627,0.00027890017,0.00027273435,0.00024605988,0.00073349004,0.00018318465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12982595,0.0013827853,0.79107183,0.0006829217,0.0018719451,0.00014169689,0.00006675215,0.0030652373,0.0138400765,0.000111348534,0.0010780332,0.056861304],"study_design_scores_gemma":[0.0046385373,0.024681557,0.9498854,0.00012517863,0.0016975825,0.0008375177,0.000057368594,0.0075857583,0.008889269,0.00022317079,0.0013399874,0.000038662067],"about_ca_topic_score_codex":0.000687613,"about_ca_topic_score_gemma":0.0011383751,"teacher_disagreement_score":0.0025158776,"about_ca_system_score_codex":0.00052718085,"about_ca_system_score_gemma":0.00055277837,"threshold_uncertainty_score":0.013305426},"labels":[],"label_agreement":null},{"id":"W4387865430","doi":"10.1158/2767-9764.crc-23-0289","title":"Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Yale University; University of British Columbia; Roswell Park Cancer Institute","keywords":"Antigen; Carcinogenesis; Cancer; Immune system; Autoantibody; Antibody; Immunology; Biology; Retrotransposon; Clinical significance; Pancreatic cancer; Cancer research; Immunoassay; Medicine; Pathology; Genetics; Gene; Genome","score_opus":0.23013557270925114,"score_gpt":0.43451549802623435,"score_spread":0.2043799253169832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387865430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959777,0.0011766278,0.00043281302,0.000095737196,0.000024008597,0.000007754842,0.0001456525,0.000034829878,0.0021049525],"genre_scores_gemma":[0.9994129,0.00011915759,0.00014341931,0.00005552012,0.000018996428,0.0000024353208,0.00007953974,0.000002181328,0.00016591647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977595,0.00006164064,0.0000135314485,0.00008396825,0.000037379345,0.000027391372],"domain_scores_gemma":[0.9995609,0.00016978469,0.00010705287,0.000029684843,0.00006229498,0.00007034532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021542069,0.0002129446,0.00017601221,0.00080077123,0.00032447575,0.00042904506,0.000122398,0.0003387969,0.0015281177],"category_scores_gemma":[0.0012427936,0.00010920076,0.00009322359,0.00033914478,0.000245501,0.00015751479,0.00013782945,0.00028686775,0.00020273378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037087355,0.0000817786,0.9649836,0.000036931368,0.00006165901,0.00064432924,0.00017933197,0.00008041406,0.017067587,0.00015068408,0.0005843631,0.015758438],"study_design_scores_gemma":[0.000017045526,0.00044086107,0.9867055,0.000017356293,0.00006756228,0.0043622693,0.00014256971,0.00033400347,0.005099083,0.00022812928,0.0025770916,0.000008610265],"about_ca_topic_score_codex":0.001157869,"about_ca_topic_score_gemma":0.00062635535,"teacher_disagreement_score":0.0015281177,"about_ca_system_score_codex":0.00023326125,"about_ca_system_score_gemma":0.000100939076,"threshold_uncertainty_score":0.005112052},"labels":[],"label_agreement":null},{"id":"W4389085040","doi":"10.1158/2767-9764.crc-23-0223","title":"Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a <i>BRCA1</i> or <i>BRCA2</i> Mutation","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Physical Activity and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Amgen (Canada); Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Institute of Genetics; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Peter Gilgan Foundation; Women's College Hospital; Cleveland Clinic","keywords":"Medicine; Ovarian cancer; Metabolic equivalent; Confidence interval; Young adult; Internal medicine; Physical activity; Cancer; Case-control study; Logistic regression; Oncology; Population; Demography; Physiology; Physical therapy; Environmental health","score_opus":0.1168879454881964,"score_gpt":0.43710140319247803,"score_spread":0.32021345770428167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389085040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931395,0.0003341695,0.000023303923,0.000018161267,0.000003242229,0.000004396519,0.0001297131,0.000001057534,0.00017209565],"genre_scores_gemma":[0.99952424,0.00015534202,0.000023023433,0.000014488936,0.0000072217977,0.0000049777373,0.00013556331,6.995912e-7,0.00013434989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997764,0.00006664761,0.000024366538,0.0000483688,0.000037713802,0.000046643],"domain_scores_gemma":[0.99922955,0.00014380095,0.00036302343,0.000052102765,0.00005758649,0.0001539859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042633584,0.00015889206,0.00026546887,0.000553373,0.00025485305,0.0003612252,0.00018186962,0.00029610304,0.00084408367],"category_scores_gemma":[0.0013945611,0.00021929585,0.00030792534,0.0005170578,0.00016184182,0.00025748028,0.00032374405,0.00030923242,0.00011503424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074698255,0.00002155277,0.9993007,0.0000031275515,0.000022397853,0.000022444146,0.000023204459,0.0000070439337,0.000056700384,0.0000040164873,0.00001764193,0.00044638047],"study_design_scores_gemma":[0.0000029904297,0.0000546454,0.99971527,0.0000023207456,0.000013602407,0.00007369349,0.00004243132,0.000035628673,0.000014742394,0.00000447216,0.000039510116,6.327429e-7],"about_ca_topic_score_codex":0.0058781286,"about_ca_topic_score_gemma":0.0076726964,"teacher_disagreement_score":0.0058781286,"about_ca_system_score_codex":0.00016060584,"about_ca_system_score_gemma":0.00013926296,"threshold_uncertainty_score":0.011687815},"labels":[],"label_agreement":null},{"id":"W4389180294","doi":"10.1158/2767-9764.crc-23-0306","title":"<i>FBXW7</i> -loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; York University; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Mitotic catastrophe; DNA damage; Biology; CHEK1; Mitosis; DNA repair; Cell biology; Cell cycle; G2-M DNA damage checkpoint; DNA replication; Mutant; Synthetic lethality; Mutation; Cell cycle checkpoint; Cancer research; Cell; Gene; Genetics; DNA","score_opus":0.09873208563061066,"score_gpt":0.4102092194617746,"score_spread":0.31147713383116393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842328,0.0018214071,0.0043051937,0.00043333875,0.000101651516,0.000053001873,0.0027536964,0.00057544705,0.0057235966],"genre_scores_gemma":[0.9890372,0.0007213928,0.002232617,0.00015909899,0.00000939789,0.000043568558,0.0021441884,0.00011206317,0.005540505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987996,0.000012379638,0.000015342604,0.00003369592,0.000031645817,0.000026984435],"domain_scores_gemma":[0.9999093,0.000019418127,0.000025248964,0.000015284506,0.0000068348386,0.000023923005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096518175,0.000385248,0.00028543817,0.0002471584,0.00015005587,0.00034565516,0.00028156445,0.00044675253,0.0031521583],"category_scores_gemma":[0.00011025199,0.0001254334,0.00024052564,0.0001497727,0.00028237954,0.00016702774,0.00022621857,0.00083727227,0.0009063835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006990669,0.000026746284,0.00016641541,0.00003532247,0.000009169955,0.00008009959,0.0000056550134,0.000091251284,0.99803525,0.00012848014,0.00019732433,0.0011543237],"study_design_scores_gemma":[0.000006866131,0.000086147644,0.0026344983,0.0000061373985,0.000008478403,0.00022951377,0.000013014314,0.0007148988,0.9936958,0.00004312535,0.0025582155,0.0000032140424],"about_ca_topic_score_codex":0.0015035728,"about_ca_topic_score_gemma":0.0018725403,"teacher_disagreement_score":0.0031521583,"about_ca_system_score_codex":0.00031202537,"about_ca_system_score_gemma":0.00020433363,"threshold_uncertainty_score":0.010545015},"labels":[],"label_agreement":null},{"id":"W4389180400","doi":"10.1158/2767-9764.crc-23-0234","title":"SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Scheme for Promotion of Academic and Research Collaboration; Canadian Institutes of Health Research; Hospital for Sick Children; Government of Canada; Novartis","keywords":"Crizotinib; Neuroblastoma; ALK inhibitor; Cancer research; Anaplastic lymphoma kinase; Ceritinib; In vivo; Biology; Cell culture; Medicine; Lung cancer; Internal medicine; Genetics","score_opus":0.0929202335907669,"score_gpt":0.4231044218699909,"score_spread":0.330184188279224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594814,0.001576692,0.00041887647,0.00007063392,0.000039885414,0.000050328374,0.00023907071,0.00006460627,0.0015917107],"genre_scores_gemma":[0.995665,0.0012165586,0.000591454,0.000037255442,0.000010965904,0.000038818565,0.0008274,0.000012157393,0.0016003911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999899,0.0000141175115,0.000010823838,0.000018933883,0.00002892725,0.000028052473],"domain_scores_gemma":[0.99994946,0.000006337358,0.00001097228,0.0000043294167,0.000005818011,0.000023044082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015406105,0.00036480252,0.0004993617,0.00022196132,0.00011842323,0.00039110368,0.000243522,0.00018304185,0.0010446969],"category_scores_gemma":[0.00014092447,0.00011436521,0.00028253358,0.00013451606,0.00015106844,0.00022639078,0.0002095152,0.00061658537,0.00024911683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006744588,0.00038509627,0.00073667825,0.00012060098,0.000037265963,0.00012225205,0.00003684571,0.0005556694,0.9862844,0.00010567993,0.00040788692,0.0105333105],"study_design_scores_gemma":[0.00038081472,0.0068799416,0.01524242,0.000033697008,0.0001433497,0.0008249944,0.000089401554,0.0025735265,0.96566087,0.00005367028,0.008095635,0.000021756177],"about_ca_topic_score_codex":0.0010588968,"about_ca_topic_score_gemma":0.0032476378,"teacher_disagreement_score":0.0010588968,"about_ca_system_score_codex":0.00039567813,"about_ca_system_score_gemma":0.0003950056,"threshold_uncertainty_score":0.0034948587},"labels":[],"label_agreement":null},{"id":"W4389436951","doi":"10.1158/2767-9764.crc-23-0361","title":"A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi; Merck KGaA; Les Laboratories Pierre Fabre; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Chugai Pharmaceutical; Servier; Göteborgs Universitet; G1 Therapeutics; Amgen","keywords":"Medicine; Oxaliplatin; Bevacizumab; Clinical endpoint; Fluorouracil; Internal medicine; Colorectal cancer; Randomized controlled trial; Adverse effect; Phases of clinical research; Bolus (digestion); Gastroenterology; Oncology; Surgery; Cancer; Clinical trial; Chemotherapy","score_opus":0.3327243693725975,"score_gpt":0.5179726216997274,"score_spread":0.18524825232712988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389436951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97954375,0.003803112,0.000906313,0.00161783,0.0011005063,0.007944155,0.0019812153,0.00014947342,0.0029535806],"genre_scores_gemma":[0.9701909,0.0027498738,0.0027894205,0.0025102238,0.0010726033,0.011671722,0.0026078734,0.000050695966,0.006356686],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987311,0.0008307536,0.000052764804,0.00015928595,0.0000835781,0.00014253892],"domain_scores_gemma":[0.99796593,0.00059895427,0.00049213547,0.00018222649,0.00012279216,0.00063796726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041255453,0.002139857,0.0029709055,0.00045061533,0.0005134039,0.0015144113,0.0012384169,0.0021675269,0.007942186],"category_scores_gemma":[0.0035298683,0.000827268,0.0020632863,0.00039115478,0.0014032685,0.001386837,0.00054443715,0.0039992314,0.0014127883],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9849504,0.0064007645,0.00036459623,0.00022178124,0.0006107299,0.000026864556,0.00003768496,0.00025612972,0.0010380582,0.00011965297,0.00084705866,0.005126338],"study_design_scores_gemma":[0.9649202,0.033191614,0.0005744657,0.000013564569,0.00022301525,0.000019536164,0.0000104147575,0.00031001572,0.00014942337,0.000101907695,0.00047730329,0.000008575447],"about_ca_topic_score_codex":0.0010713781,"about_ca_topic_score_gemma":0.002180825,"teacher_disagreement_score":0.007942186,"about_ca_system_score_codex":0.001219259,"about_ca_system_score_gemma":0.0017808895,"threshold_uncertainty_score":0.026569307},"labels":[],"label_agreement":null},{"id":"W4391644521","doi":"10.1158/2767-9764.crc-23-0409","title":"Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Sinai Health System; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; National Institutes of Health; Bayer HealthCare; Flatiron Health; Seagen; Gilead Sciences; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Colorectal cancer; Cancer; Oncology; Internal medicine","score_opus":0.07539687396634995,"score_gpt":0.43334037967332933,"score_spread":0.3579435057069794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391644521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221534,0.0002591397,0.00025215946,0.00009346563,0.0000042182355,0.00002035042,0.0064625014,0.000011786594,0.00068099744],"genre_scores_gemma":[0.9899441,0.00016492496,0.0002636205,0.000053237032,0.000013508977,0.00005255056,0.009346898,0.0000072177577,0.00015402297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989335,0.00030920716,0.00013008507,0.00033001872,0.00019031996,0.00010692529],"domain_scores_gemma":[0.99734914,0.00051432877,0.0012910846,0.00036571448,0.00029695002,0.00018279509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010599238,0.00015927265,0.00038464743,0.0010708653,0.00030208245,0.0005500632,0.00044579577,0.00033038604,0.0012129563],"category_scores_gemma":[0.0039334507,0.00015828433,0.00019466998,0.0016512163,0.00019021281,0.00030570867,0.0005155401,0.0003125771,0.00029627586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001029246,0.000012825522,0.99675226,0.000016097272,0.000030648545,0.00009958399,0.000052040898,0.00007941088,0.00031939225,0.00003434966,0.0006386974,0.0018618105],"study_design_scores_gemma":[0.000011831868,0.00003860244,0.99834883,0.0000062154713,0.000023823633,0.00043539423,0.0000645771,0.00023727618,0.00011359552,0.000021368935,0.0006944819,0.000004072242],"about_ca_topic_score_codex":0.0053841155,"about_ca_topic_score_gemma":0.0074665355,"teacher_disagreement_score":0.0053841155,"about_ca_system_score_codex":0.00038782018,"about_ca_system_score_gemma":0.0003788892,"threshold_uncertainty_score":0.010705531},"labels":[],"label_agreement":null},{"id":"W4391884468","doi":"10.1158/2767-9764.crc-23-0571","title":"Cancer-associated Fibroblast–specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Alberta; University of Saskatchewan; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Arthritis Society","keywords":"Matricellular protein; Stroma; Metastasis; Neovascularization; Cancer; Cancer research; Melanoma; Pathology; Cancer-Associated Fibroblasts; Biology; Extracellular matrix; Immunohistochemistry; Medicine; Cell biology; Angiogenesis; Genetics","score_opus":0.05572409140274851,"score_gpt":0.37153160226177345,"score_spread":0.3158075108590249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391884468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486864,0.0013361571,0.0018929522,0.00007669777,0.000013006137,0.000027518767,0.00020396717,0.00005983536,0.0015211183],"genre_scores_gemma":[0.99761605,0.00037467704,0.0008453049,0.00001923317,0.0000028311845,0.000017502918,0.00010683307,0.000005070893,0.0010124939],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993134,0.000009072212,0.0000037131367,0.000014577515,0.000026187128,0.000015116699],"domain_scores_gemma":[0.9999522,0.000003733803,0.000014414757,0.0000037052657,0.000007005983,0.000018870101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007780341,0.0001615666,0.000112878835,0.00023367128,0.00013219228,0.0001501721,0.000067265275,0.0001572135,0.00063017587],"category_scores_gemma":[0.0000910404,0.000098115306,0.000110939276,0.00008838852,0.00012787801,0.00009267521,0.00011988506,0.00030790624,0.00013643464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044568562,0.000010522942,0.00050117506,0.000015135286,0.000002048684,0.00005580999,0.000012645317,0.0000650168,0.9981997,0.0000855171,0.00004944274,0.00095825095],"study_design_scores_gemma":[0.000023947117,0.00032103533,0.079095505,0.000011899969,0.000021071875,0.0014725181,0.000092622664,0.006326494,0.9070067,0.00025098864,0.0053654322,0.00001193946],"about_ca_topic_score_codex":0.0016975341,"about_ca_topic_score_gemma":0.002135757,"teacher_disagreement_score":0.0016975341,"about_ca_system_score_codex":0.00026826715,"about_ca_system_score_gemma":0.00019517458,"threshold_uncertainty_score":0.0033752918},"labels":[],"label_agreement":null},{"id":"W4391884527","doi":"10.1158/2767-9764.crc-22-0516","title":"CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Chugai Pharmaceutical; Stand Up To Cancer; Genentech; Ipsen; Servier; Eisai; Incyte; Astex Pharmaceuticals; Novocure; Sanofi; Exelixis; BioClinica; Regeneron Pharmaceuticals; National Institutes of Health; Helsinn; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Hepatitis C virus; Internal medicine; Hepatitis C; Titer; Gastroenterology; Hepacivirus; Discontinuation; Immunology; Oncology; Virus","score_opus":0.07582060412169538,"score_gpt":0.4308331225200983,"score_spread":0.3550125183984029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391884527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932822,0.0044993456,0.00007436587,0.00051541626,0.0000853669,0.0001356809,0.00025969086,0.000023356646,0.0011244894],"genre_scores_gemma":[0.99602133,0.0018295208,0.00021680372,0.00043476583,0.000095892436,0.00010132134,0.000717637,0.0000048375246,0.00057789084],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99962103,0.0001827555,0.000027928994,0.00006363139,0.0000448445,0.000059841812],"domain_scores_gemma":[0.999463,0.00011507697,0.00012628587,0.000030533334,0.000039222028,0.00022592125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00123832,0.00049184303,0.0013092902,0.00028002,0.0002371613,0.0005625437,0.0003635388,0.0005325708,0.0016126711],"category_scores_gemma":[0.0015873777,0.00020756303,0.0010153721,0.00034530638,0.00033912278,0.0006301062,0.00040913603,0.0012000107,0.00022639983],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68218887,0.008229419,0.062315654,0.0010570961,0.0031616476,0.00016627353,0.00012143957,0.001995645,0.0083244955,0.00024320024,0.004111442,0.2280848],"study_design_scores_gemma":[0.3439173,0.17329454,0.46607748,0.00022609277,0.0044354987,0.0004986012,0.00018054126,0.00398538,0.0015195039,0.0004076621,0.0053732297,0.00008414496],"about_ca_topic_score_codex":0.0030561148,"about_ca_topic_score_gemma":0.009002565,"teacher_disagreement_score":0.0030561148,"about_ca_system_score_codex":0.0008437591,"about_ca_system_score_gemma":0.0010842981,"threshold_uncertainty_score":0.006548941},"labels":[],"label_agreement":null},{"id":"W4392298413","doi":"10.1158/2767-9764.crc-23-0269","title":"Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Terry Fox Research Institute; Princess Margaret Cancer Foundation","keywords":"Photodynamic therapy; Basal cell; Oral cavity; Medicine; Cancer research; Oncology; Pathology; Chemistry; Dentistry","score_opus":0.21334741227809056,"score_gpt":0.5269626874590205,"score_spread":0.31361527518092996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392298413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766282,0.002083034,0.015930165,0.00019356202,0.000084552354,0.0006334851,0.00068669586,0.0003564509,0.0034040317],"genre_scores_gemma":[0.9730489,0.0025852178,0.01521833,0.00006954543,0.000013064658,0.00065080257,0.0007452833,0.00005215502,0.0076165632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998301,0.000021742317,0.0000108305885,0.00003691276,0.00006463198,0.000035732708],"domain_scores_gemma":[0.99994004,0.000009962689,0.000011794722,0.000012359242,0.000013620148,0.000012234115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003108955,0.0006148636,0.0004177424,0.00035105387,0.00019231274,0.00030222995,0.00038710874,0.00046648574,0.0010213753],"category_scores_gemma":[0.00008687022,0.0002222241,0.0003570811,0.00018325578,0.00022009792,0.00020073965,0.0001575818,0.00093617797,0.00043021078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040635674,0.0001067455,0.000044105396,0.000035032677,0.000004387723,0.000018783176,0.000016014339,0.00017938176,0.9984491,0.00006448874,0.000052678624,0.0009885784],"study_design_scores_gemma":[0.00001598178,0.0011320298,0.000506616,0.0000040387768,0.000018179913,0.000072338335,0.000011038628,0.0009660032,0.9957124,0.00001962142,0.0015384669,0.0000032934565],"about_ca_topic_score_codex":0.0023065798,"about_ca_topic_score_gemma":0.0035563528,"teacher_disagreement_score":0.0023065798,"about_ca_system_score_codex":0.00046728482,"about_ca_system_score_gemma":0.00044747538,"threshold_uncertainty_score":0.004586339},"labels":[],"label_agreement":null},{"id":"W4392298469","doi":"10.1158/2767-9764.crc-23-0376","title":"Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Canadian Institutes of Health Research; Canada First Research Excellence Fund; Terry Fox Research Institute","keywords":"Dabrafenib; Function (biology); Immunologic function; Chemistry; Cell biology; Neuroscience; Medicine; Cancer research; Biology; Immunology; Immune system; Melanoma","score_opus":0.07591477353296165,"score_gpt":0.3923209270614251,"score_spread":0.3164061535284634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392298469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955947,0.0015482017,0.000865063,0.00009597411,0.000017128199,0.00002275124,0.00052898395,0.000046189758,0.0012810829],"genre_scores_gemma":[0.9972356,0.0006076084,0.0004575353,0.00004283382,0.0000043476643,0.000031398533,0.00051575,0.000005827102,0.0010990397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988985,0.000016664573,0.0000074689524,0.000021676926,0.000031840267,0.000032458072],"domain_scores_gemma":[0.9999745,0.0000028622308,0.000007970487,0.000002646149,0.0000033310228,0.000008735979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081675804,0.00026206562,0.00018607295,0.0001761593,0.00010013531,0.00020616973,0.00008927209,0.00011900123,0.001082261],"category_scores_gemma":[0.0000713832,0.00006108261,0.00014425862,0.00011484473,0.00013055488,0.00008808846,0.00007489327,0.00032313383,0.00017930882],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039877833,0.00005043444,0.0007809279,0.000036222573,0.0000071212908,0.000032137177,0.0000098726105,0.00016805614,0.99553466,0.000103875915,0.00007830049,0.0027997126],"study_design_scores_gemma":[0.000054742144,0.0006268271,0.013500457,0.0000065428253,0.000019864197,0.000252757,0.000042776093,0.0017097004,0.97769815,0.00009899069,0.0059845275,0.000004741291],"about_ca_topic_score_codex":0.00081568427,"about_ca_topic_score_gemma":0.0016882722,"teacher_disagreement_score":0.001082261,"about_ca_system_score_codex":0.00032558356,"about_ca_system_score_gemma":0.00025414064,"threshold_uncertainty_score":0.003620565},"labels":[],"label_agreement":null},{"id":"W4393026261","doi":"10.1158/2767-9764.crc-23-0384","title":"Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; McGill University","keywords":"Mimotope; Immunogenicity; Epitope; Biology; Virology; Antigen; Immunology","score_opus":0.09703523020333038,"score_gpt":0.4529567443100348,"score_spread":0.3559215141067044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393026261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943039,0.0005496177,0.0042605065,0.000036759953,0.000012408146,0.00008619124,0.00012158693,0.000036433106,0.0005925863],"genre_scores_gemma":[0.9912321,0.00037427613,0.0071435943,0.000049817747,0.000006194933,0.000053443073,0.0002683234,0.000011913599,0.00086032704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986565,0.000021168473,0.000008832415,0.000029067955,0.00003629515,0.000038973492],"domain_scores_gemma":[0.9999006,0.000017917415,0.00002724173,0.000008976637,0.000013936674,0.000031261556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020651086,0.00033333534,0.00022913239,0.0001652798,0.000091910246,0.00023736853,0.00021272786,0.00035752682,0.0005883516],"category_scores_gemma":[0.00015287587,0.00012358227,0.00023819465,0.00010220303,0.00018076919,0.00016247717,0.00021509641,0.00049781596,0.00022595796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055773427,0.000040715575,0.00014787755,0.000019412675,0.000005014197,0.00004292776,0.000009268846,0.00023868197,0.99840516,0.000059430833,0.00002393374,0.00095188053],"study_design_scores_gemma":[0.00003369088,0.0012497744,0.0020354711,0.000005334165,0.000017696795,0.00024512148,0.00001536784,0.0016519345,0.9933696,0.000029454703,0.00134044,0.00000611108],"about_ca_topic_score_codex":0.0002959176,"about_ca_topic_score_gemma":0.0005874128,"teacher_disagreement_score":0.0005883516,"about_ca_system_score_codex":0.00030227375,"about_ca_system_score_gemma":0.00016647585,"threshold_uncertainty_score":0.002193153},"labels":[],"label_agreement":null},{"id":"W4394567449","doi":"10.1158/2767-9764.crc-23-0519","title":"<i>Actívatexto:</i> Feasibility and Acceptability of a Mobile Intervention That Promotes Smoking Cessation and Physical Activity among Latinos","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"Genentech; National Institute of Environmental Health Sciences; American Association for Cancer Research","keywords":"Smoking cessation; Medicine; Abstinence; Nicotine replacement therapy; Physical activity; Intervention (counseling); Physical therapy; Psychiatry","score_opus":0.2299298449951721,"score_gpt":0.5019009863141938,"score_spread":0.27197114131902167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394567449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936451,0.000043006672,0.0007578517,0.00026758472,0.000022895278,0.0026412853,0.00030233228,0.000060413542,0.0022595548],"genre_scores_gemma":[0.96814495,0.00021259116,0.008755597,0.0006794987,0.000078918936,0.01735145,0.00062134553,0.00003554656,0.004120144],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989768,0.00058795366,0.00008331477,0.000076729666,0.00012668222,0.00014845395],"domain_scores_gemma":[0.9990615,0.0003261995,0.00017897866,0.0000742751,0.00017225032,0.00018684479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035822918,0.00041462094,0.00031375192,0.0002685653,0.00062569097,0.00063639466,0.00044813976,0.0005117145,0.0061306236],"category_scores_gemma":[0.0033759002,0.00019349359,0.00044361455,0.00011007646,0.00032252996,0.0005390502,0.0007975298,0.00036632945,0.00066580955],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037175633,0.05882846,0.26185116,0.0023024601,0.0004175167,0.0006891563,0.01595416,0.0008652864,0.066218466,0.00081955706,0.008511677,0.5463665],"study_design_scores_gemma":[0.016541589,0.15772843,0.73068863,0.0010308876,0.0010669753,0.0006064626,0.017766666,0.002993151,0.034982193,0.00052031595,0.035889376,0.00018522269],"about_ca_topic_score_codex":0.0020217975,"about_ca_topic_score_gemma":0.0039801486,"teacher_disagreement_score":0.0061306236,"about_ca_system_score_codex":0.00032928862,"about_ca_system_score_gemma":0.0009834222,"threshold_uncertainty_score":0.020509005},"labels":[],"label_agreement":null},{"id":"W4395663602","doi":"10.1158/2767-9764.crc-23-0459","title":"First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"Merck KGaA; Pfizer","keywords":"Javelin; Avelumab; Chemotherapy; Medicine; Solid tumor; Oncology; Internal medicine; Cancer; Immunotherapy; Pembrolizumab; Physics","score_opus":0.08169363019912536,"score_gpt":0.4397402393431038,"score_spread":0.35804660914397846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395663602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837683,0.01054134,0.00041978285,0.00064020895,0.00008992316,0.00058046274,0.0015258637,0.000062150066,0.002371849],"genre_scores_gemma":[0.98321414,0.005948255,0.0015127427,0.0012905118,0.00015793047,0.0004950301,0.004682164,0.000032398166,0.0026668005],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996474,0.00019689674,0.000021541031,0.000049144586,0.000045035802,0.000039962113],"domain_scores_gemma":[0.9994116,0.000086328924,0.00016252755,0.000048355665,0.000048950824,0.00024226465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011971046,0.00045681794,0.00086713734,0.0001879635,0.00017187807,0.00066895253,0.00039840862,0.0005315499,0.0016902238],"category_scores_gemma":[0.00072817045,0.0002038524,0.00093975046,0.00025745548,0.00030834394,0.00049621327,0.00025657384,0.0014752545,0.00041314357],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5088803,0.041988507,0.039791778,0.002793415,0.003873277,0.00027946272,0.00032526164,0.0035132582,0.05689209,0.00046921818,0.015602412,0.32559097],"study_design_scores_gemma":[0.46724465,0.3971245,0.09410829,0.00030614444,0.00280489,0.0009789468,0.00014085633,0.002922183,0.011607523,0.00035112558,0.022346407,0.00006445153],"about_ca_topic_score_codex":0.00067850045,"about_ca_topic_score_gemma":0.002669194,"teacher_disagreement_score":0.0016902238,"about_ca_system_score_codex":0.0006113549,"about_ca_system_score_gemma":0.0009052792,"threshold_uncertainty_score":0.006330967},"labels":[],"label_agreement":null},{"id":"W4396676987","doi":"10.1158/2767-9764.crc-24-0031","title":"Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"AI in cancer detection","field":"Computer Science","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institutes of Health; National Cancer Institute; Sanofi; Mayo Clinic; Center for Cancer Research","keywords":"Colorectal cancer; Deep learning; Artificial intelligence; Medicine; Internal medicine; Oncology; Cancer; Computer science","score_opus":0.18696357518641435,"score_gpt":0.44859527983426,"score_spread":0.2616317046478457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396676987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474983,0.0009608371,0.049154587,0.0004602999,0.000022926306,0.00005009916,0.0006869351,0.0002965927,0.0008695043],"genre_scores_gemma":[0.991231,0.00012419878,0.0077937394,0.000038171424,0.000013581837,0.00003111601,0.00048529822,0.000008284046,0.00027444295],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99967325,0.00016038385,0.000022071052,0.000059045375,0.000041733816,0.000043564825],"domain_scores_gemma":[0.9988876,0.00065773027,0.00019337972,0.000068568705,0.000118051576,0.00007475851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012944575,0.000544516,0.00042148048,0.00084454985,0.00015078479,0.0005987898,0.00034198,0.00031567278,0.0006108787],"category_scores_gemma":[0.0034139713,0.00020978827,0.00040551383,0.0004675377,0.00020653727,0.00039812239,0.00051629415,0.00058364077,0.00013355748],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016019774,0.00060876785,0.5894923,0.000114622584,0.000695701,0.0001443768,0.00007765633,0.14623244,0.008645593,0.00092399155,0.001730341,0.24973217],"study_design_scores_gemma":[0.00005958898,0.0002952797,0.05153511,0.000017399594,0.00009184436,0.00008373265,0.000028286264,0.9433371,0.0022884884,0.0019248807,0.00031683358,0.000021499649],"about_ca_topic_score_codex":0.004547743,"about_ca_topic_score_gemma":0.006046484,"teacher_disagreement_score":0.004547743,"about_ca_system_score_codex":0.000618289,"about_ca_system_score_gemma":0.000603975,"threshold_uncertainty_score":0.009042561},"labels":[],"label_agreement":null},{"id":"W4399365549","doi":"10.1158/2767-9764.crc-24-0048","title":"Cancer-Related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition’s 2022 Global Patient Survey","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pharmacyclics; Gilead Sciences; Kite Pharma; Incyte; AbbVie; Roche; Novartis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Allergan; AstraZeneca United States","keywords":"Chronic lymphocytic leukemia; Medicine; Lymphoma; Context (archaeology); Incidence (geometry); Etiology; Survivorship curve; Cancer; Internal medicine; Population; Disease; Oncology; Leukemia; Malignant lymphoma; Environmental health","score_opus":0.0766901425229995,"score_gpt":0.43041275368428644,"score_spread":0.35372261116128695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399365549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939955,0.0012710757,0.00009655196,0.00050642225,0.000013821351,0.000024287365,0.003575833,0.000005995782,0.00051054166],"genre_scores_gemma":[0.99738854,0.0003310962,0.000052082756,0.0001531513,0.000016210768,0.000023535886,0.0019260894,0.0000029728194,0.00010625125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987783,0.00069488,0.000114008464,0.00010601057,0.00015569545,0.00015105093],"domain_scores_gemma":[0.99754,0.00055673363,0.0011132782,0.00014332906,0.00023460695,0.00041201903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018036796,0.000180186,0.00039720212,0.0008694515,0.00023536527,0.00044844832,0.00030000394,0.00036183195,0.0011453775],"category_scores_gemma":[0.004625185,0.0001519452,0.0011088331,0.0019011996,0.00017151854,0.00041730562,0.00079096225,0.0006614686,0.00014447654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011999859,0.000024193787,0.997494,0.000025032296,0.000164463,0.000020986217,0.000048527807,0.00006462847,0.000021937456,0.00001294342,0.00043088608,0.0015723873],"study_design_scores_gemma":[0.000007548934,0.00005257328,0.9993674,0.000008565826,0.00004486905,0.000035232668,0.00010538925,0.00012230009,0.0000056773342,0.0000083416635,0.00023952892,0.0000024708283],"about_ca_topic_score_codex":0.016989196,"about_ca_topic_score_gemma":0.024299946,"teacher_disagreement_score":0.016989196,"about_ca_system_score_codex":0.00063053216,"about_ca_system_score_gemma":0.00058383105,"threshold_uncertainty_score":0.033780634},"labels":[],"label_agreement":null},{"id":"W4399806161","doi":"10.1158/2767-9764.crc-23-0464","title":"KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"KRAS; GLI2; Cancer research; Transcription (linguistics); Carcinogenesis; Transcription factor; Pancreatic cancer; Chemistry; Biology; Internal medicine; Medicine; Genetics; Mutation; Gene; Cancer","score_opus":0.19194497592065668,"score_gpt":0.4782653957776401,"score_spread":0.2863204198569834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399806161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506605,0.00083463604,0.0020556964,0.0001197064,0.000019211837,0.000017030194,0.00042272473,0.00014709415,0.0013177549],"genre_scores_gemma":[0.9947286,0.0004697427,0.0013368395,0.00005757853,0.0000062828076,0.000024956043,0.00048999995,0.000029798852,0.0028560923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998895,0.000015718806,0.000009082653,0.000026824586,0.000030173302,0.000028722921],"domain_scores_gemma":[0.9998965,0.000011366549,0.000032758348,0.000013442308,0.000011584888,0.00003430666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107849344,0.00024654059,0.00017469768,0.00033330292,0.00013271593,0.00027547445,0.00011192032,0.00018165715,0.0014647509],"category_scores_gemma":[0.00008260619,0.00023603294,0.00021523921,0.0001526239,0.00023789417,0.00011436019,0.00033892808,0.0004524342,0.00049576204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015885403,0.000009385882,0.0004771836,0.00001319524,0.0000019923905,0.00004836682,0.000008597647,0.000032009182,0.99864346,0.000049673148,0.000027409968,0.0005298557],"study_design_scores_gemma":[0.000017939743,0.00016010622,0.018978909,0.00000589138,0.0000107056,0.00031935595,0.000041853364,0.00089585455,0.977777,0.000106072104,0.0016809179,0.000005337434],"about_ca_topic_score_codex":0.00085839006,"about_ca_topic_score_gemma":0.0016374321,"teacher_disagreement_score":0.0014647509,"about_ca_system_score_codex":0.0002878985,"about_ca_system_score_gemma":0.00024600758,"threshold_uncertainty_score":0.004900098},"labels":[],"label_agreement":null},{"id":"W4399891500","doi":"10.1158/2767-9764.crc-23-0334","title":"PTP4A2 Promotes Glioblastoma Progression and Macrophage Polarization under Microenvironmental Pressure","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Tumor microenvironment; Glioblastoma; Cell growth; Tumor progression; Apoptosis; In vitro; Glioma; Spheroid; Biology; Cancer; Chemistry; Medicine; Tumor cells; Internal medicine","score_opus":0.03352337779728468,"score_gpt":0.3976017331967693,"score_spread":0.3640783553994846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399891500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670887,0.0014729599,0.00076810224,0.00010023365,0.000020690537,0.0000116703595,0.00016610457,0.00005072773,0.0007005275],"genre_scores_gemma":[0.99766785,0.0005792661,0.0003119893,0.000041391842,0.000008835579,0.00002043037,0.00020258075,0.0000048852207,0.0011627837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999188,0.00000922738,0.000005836132,0.0000128175725,0.000019888628,0.000033343797],"domain_scores_gemma":[0.9999542,0.0000021967112,0.000014539472,0.0000031117875,0.000006150884,0.000019741197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009418738,0.00022432052,0.00018491833,0.00021632118,0.00012444802,0.00019736371,0.000072569215,0.00014614464,0.0009867577],"category_scores_gemma":[0.00004932076,0.00007908765,0.00017034587,0.00013287432,0.00015238105,0.000110826244,0.00018380175,0.00045285924,0.00018244209],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003597133,0.000058555604,0.0010985926,0.000043171833,0.00000912163,0.00005627227,0.000011998232,0.000053718835,0.99611306,0.000046779438,0.00011168624,0.002037286],"study_design_scores_gemma":[0.00009139072,0.0011855618,0.055667683,0.00001172504,0.000050567396,0.00054692425,0.00011759896,0.002272109,0.9358746,0.0001359237,0.0040383996,0.0000075225767],"about_ca_topic_score_codex":0.00079574017,"about_ca_topic_score_gemma":0.0012862466,"teacher_disagreement_score":0.0009867577,"about_ca_system_score_codex":0.00019371104,"about_ca_system_score_gemma":0.00026812754,"threshold_uncertainty_score":0.0033010244},"labels":[],"label_agreement":null},{"id":"W4400093522","doi":"10.1158/2767-9764.crc-23-0355","title":"Putrescine Supplementation Limits the Expansion of <i>pks</i> + <i>Escherichia coli</i> and Tumor Development in the Colon","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Escherichia coli; Azoxymethane; Putrescine; Biology; Metabolome; Microbiology; Bacteria; Probiotic; Bacteroidetes; Firmicutes; Gut flora; Biochemistry; Metabolite; Enzyme; Gene; 16S ribosomal RNA; Genetics; Carcinogenesis","score_opus":0.07088852213335436,"score_gpt":0.4063819860865301,"score_spread":0.3354934639531757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400093522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981869,0.0005594623,0.00035596418,0.00006549834,0.000016003127,0.000020612775,0.0001648732,0.000035143326,0.0005955096],"genre_scores_gemma":[0.99546576,0.00047510848,0.0015829399,0.00009084872,0.0000130391245,0.000030166126,0.00071660016,0.000025525618,0.0015998633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998018,0.000044889326,0.000028662584,0.000031606785,0.00005377993,0.00003940497],"domain_scores_gemma":[0.9997813,0.00003067582,0.000057839883,0.000020072235,0.000030059322,0.000080117075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011012548,0.0003816667,0.0003846036,0.000169667,0.00009173669,0.00029344612,0.00022862457,0.00028445097,0.00093559973],"category_scores_gemma":[0.00023026268,0.00014571966,0.00019152113,0.00010560405,0.00016503395,0.00014828742,0.00021265242,0.0004195431,0.00023372743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068822026,0.00008321571,0.00021201518,0.000028876038,0.0000049806727,0.000022229438,0.0000058057676,0.000038841325,0.9978376,0.00001159607,0.00002360003,0.0010428907],"study_design_scores_gemma":[0.000040187217,0.0032790499,0.008428324,0.000012166191,0.00002565556,0.00013752675,0.000041025392,0.000539787,0.986108,0.00001463693,0.0013670893,0.0000065599575],"about_ca_topic_score_codex":0.00091511494,"about_ca_topic_score_gemma":0.0020350823,"teacher_disagreement_score":0.00093559973,"about_ca_system_score_codex":0.00017938545,"about_ca_system_score_gemma":0.00023429036,"threshold_uncertainty_score":0.003129959},"labels":[],"label_agreement":null},{"id":"W4400228534","doi":"10.1158/2767-9764.crc-24-0113","title":"mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of <i>PIK3CA</i> -Altered Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Genome British Columbia; University of Victoria; McGill University; Research Manitoba; Jewish General Hospital","funders":"","keywords":"mTORC1; PI3K/AKT/mTOR pathway; Fulvestrant; Cancer research; Medicine; Oncology; Internal medicine; Translation (biology); Breast cancer; Clinical trial; Cancer; Biology; Signal transduction; Gene; Genetics; Messenger RNA","score_opus":0.09867638834535514,"score_gpt":0.42521902088070773,"score_spread":0.3265426325353526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400228534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995091,0.00011619257,0.000051613762,0.000010432846,0.0000017556972,0.0000036787396,0.00011854959,0.0000039960682,0.00018473926],"genre_scores_gemma":[0.9994373,0.000052405598,0.00006964763,0.000018665382,0.0000028283575,0.000007322809,0.00030341043,0.0000030095136,0.00010545896],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998518,0.00001849924,0.000012744995,0.00004876569,0.000030391904,0.000037698268],"domain_scores_gemma":[0.9997813,0.000041844945,0.00007846459,0.000018654435,0.000019089583,0.000060711078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018132593,0.00016471751,0.0003103426,0.00030660562,0.0001419853,0.00037035215,0.00007708838,0.00017761333,0.00080051523],"category_scores_gemma":[0.0003409552,0.000112775444,0.0001501764,0.0002512057,0.00020359812,0.00012936683,0.0001406577,0.00041714797,0.0001507142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006659869,0.00034549608,0.20118809,0.000030943513,0.00014334673,0.00029714033,0.000072950264,0.0005914029,0.7814132,0.00006905673,0.00034533965,0.008843153],"study_design_scores_gemma":[0.00008991992,0.0023326634,0.9096306,0.0000035675814,0.000107505984,0.001436332,0.000088093635,0.0017340182,0.0839024,0.00006125875,0.0006033534,0.000010295433],"about_ca_topic_score_codex":0.0006340593,"about_ca_topic_score_gemma":0.000767976,"teacher_disagreement_score":0.00080051523,"about_ca_system_score_codex":0.00024182946,"about_ca_system_score_gemma":0.00013549159,"threshold_uncertainty_score":0.002677977},"labels":[],"label_agreement":null},{"id":"W4400657012","doi":"10.1158/2767-9764.crc-24-0196","title":"Estrogen Receptor Blockade Potentiates Immunotherapy for Liver Metastases by Altering the Liver Immunosuppressive Microenvironment","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Tumor microenvironment; CCL5; Immunotherapy; Cancer research; Fulvestrant; Immune system; Estrogen; Chemokine; Estrogen receptor; Immunosurveillance; Chemokine receptor; Metastasis; Medicine; Biology; T cell; Internal medicine; Immunology; Cancer; IL-2 receptor; Breast cancer","score_opus":0.06896235462557136,"score_gpt":0.37458375142484307,"score_spread":0.3056213967992717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400657012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939838,0.003716655,0.00068369816,0.00013546088,0.000045503806,0.00002876756,0.00015374958,0.00005055161,0.0012017629],"genre_scores_gemma":[0.9956232,0.0020257966,0.00055717427,0.00009072446,0.000022698858,0.000030140582,0.00019174378,0.0000067230226,0.0014519361],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999299,0.000015587162,0.000006452766,0.000010018669,0.000014707275,0.000023366303],"domain_scores_gemma":[0.9999664,0.000008133788,0.000008828294,0.0000039167135,0.0000032816502,0.000009411024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107434455,0.00019027358,0.00026762235,0.0001342618,0.00005956976,0.00014878498,0.00009596331,0.00014657839,0.0010858683],"category_scores_gemma":[0.00007741369,0.000059948037,0.00020047494,0.00006657956,0.00011349566,0.00010992792,0.00011904128,0.00039256984,0.00016325334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007531689,0.00019500272,0.0004259217,0.00009293283,0.000017720075,0.000058131038,0.000018364646,0.00025753325,0.98628265,0.000079523175,0.00012118357,0.011697883],"study_design_scores_gemma":[0.00021455447,0.008417714,0.011190994,0.000020544976,0.00008512368,0.0003548637,0.000054697903,0.001310342,0.96986324,0.00009940337,0.008379545,0.000008933617],"about_ca_topic_score_codex":0.0002147288,"about_ca_topic_score_gemma":0.00082459766,"teacher_disagreement_score":0.0010858683,"about_ca_system_score_codex":0.00010038856,"about_ca_system_score_gemma":0.00016477295,"threshold_uncertainty_score":0.003632605},"labels":[],"label_agreement":null},{"id":"W4401751779","doi":"10.1158/2767-9764.crc-24-0101","title":"Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Sinai Health System; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; CancerCare Manitoba; University of Toronto","funders":"Krembil Foundation; Centre Léon Bérard; Agence Nationale de la Recherche; CancerCare Manitoba Foundation; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cytostasis; Netrin; Integrin; Cell biology; Chemistry; Biology; Biochemistry; Receptor; Cytotoxicity","score_opus":0.10923584673785962,"score_gpt":0.440136647642519,"score_spread":0.33090080090465934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401751779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940791,0.0008916247,0.0022774003,0.00006941723,0.0000139733565,0.000011461409,0.00018302367,0.00007996657,0.0023941682],"genre_scores_gemma":[0.994764,0.00033425298,0.001228927,0.000031317664,0.000002387978,0.00001256729,0.00032425503,0.000015730504,0.0032865845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987316,0.000011870948,0.000009992718,0.000028328974,0.000041968535,0.000034617948],"domain_scores_gemma":[0.9999306,0.000006952108,0.000026991955,0.000008042926,0.0000036626404,0.00002378166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068524925,0.00030350595,0.00012777197,0.00015584068,0.00015531226,0.00028868543,0.00016778053,0.00020458667,0.0013573801],"category_scores_gemma":[0.00005112984,0.00014891486,0.00022693278,0.00008772448,0.00014709546,0.00015827313,0.00037566214,0.0003296316,0.00038835808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005651483,0.000009300723,0.0003367969,0.000015871205,0.0000055786163,0.000046335743,0.0000069180805,0.00007384517,0.9981748,0.00017404521,0.000034981193,0.0010648987],"study_design_scores_gemma":[0.000008867317,0.00011215097,0.0055034333,0.0000038456888,0.000015035486,0.00032156336,0.000025235426,0.0012376333,0.98983955,0.000038017675,0.002891587,0.0000031563407],"about_ca_topic_score_codex":0.0005953194,"about_ca_topic_score_gemma":0.0020964993,"teacher_disagreement_score":0.0013573801,"about_ca_system_score_codex":0.00035151766,"about_ca_system_score_gemma":0.0001447711,"threshold_uncertainty_score":0.0045408607},"labels":[],"label_agreement":null},{"id":"W4401779089","doi":"10.1158/2767-9764.crc-24-0292","title":"The Proteogenomics of Prostate Cancer Radioresistance","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"U.S. National Library of Medicine; Instituto Tecnológico de Costa Rica; National Cancer Institute; National Medical Research Council; University of Toronto; Prostate Cancer Canada; Medical Research Council; Duke-NUS Medical School; Prostate Cancer Foundation; Movember Foundation; National Institutes of Health; Cancer Research UK; Sunnybrook Foundation; U.S. Department of Defense","keywords":"Proteogenomics; Radioresistance; Prostate cancer; Prostate; Cancer; Medicine; Oncology; Cancer research; Internal medicine; Biology; Radiation therapy","score_opus":0.13958524073596099,"score_gpt":0.47609397036659623,"score_spread":0.3365087296306353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401779089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704137,0.014269495,0.008791596,0.0008124816,0.000061750216,0.000051771625,0.0035222487,0.00017664093,0.0019003608],"genre_scores_gemma":[0.9840329,0.005624338,0.0043823114,0.0003609087,0.000041567935,0.000042764394,0.00376959,0.000032688717,0.0017129296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987924,0.000020824913,0.0000066088373,0.000037371836,0.00003491793,0.000021062477],"domain_scores_gemma":[0.99989355,0.000015769727,0.000042086263,0.000011128578,0.000022857279,0.000014551491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025194662,0.00025866996,0.00029495204,0.0005979759,0.0002376423,0.0005956741,0.00012340694,0.00024005165,0.000592013],"category_scores_gemma":[0.0002391755,0.00012817197,0.00028924688,0.0005936188,0.00020653056,0.00026117888,0.00028541562,0.00042488074,0.00024832503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015840943,0.00003446798,0.009270882,0.00022698657,0.00009199986,0.00012960234,0.00008056422,0.0004971322,0.9757463,0.0004408335,0.00054281444,0.012780056],"study_design_scores_gemma":[0.000033602497,0.00048664663,0.6003076,0.000084601954,0.00025379873,0.0023552184,0.0004428676,0.009900792,0.35838667,0.0040241154,0.023648433,0.00007563266],"about_ca_topic_score_codex":0.00042906366,"about_ca_topic_score_gemma":0.0005672854,"teacher_disagreement_score":0.0005979759,"about_ca_system_score_codex":0.00027471542,"about_ca_system_score_gemma":0.0002473043,"threshold_uncertainty_score":0.001993239},"labels":[],"label_agreement":null},{"id":"W4402865322","doi":"10.1158/2767-9764.crc-24-0268","title":"ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt Pathway","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada); Discovery Centre","funders":"","keywords":"Wnt signaling pathway; ATF6; Unfolded protein response; Cell biology; Organoid; Biology; Cancer research; Cell growth; Frizzled; Endoplasmic reticulum; Signal transduction; Genetics","score_opus":0.044888252405469425,"score_gpt":0.3832452394018077,"score_spread":0.3383569869963383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402865322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990715,0.0031929503,0.0028017126,0.00035033852,0.000049302267,0.00002278417,0.0008366467,0.00017320072,0.0026659265],"genre_scores_gemma":[0.9945655,0.0011088753,0.0014306172,0.00005255225,0.000009346993,0.00001203955,0.00040633057,0.000013354136,0.002401333],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999941,0.000009355342,0.0000055856685,0.000009335894,0.000017829569,0.000016872553],"domain_scores_gemma":[0.99994314,0.0000047381372,0.000015855954,0.0000051503507,0.000008600737,0.000022501066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072026494,0.00022781729,0.0001571868,0.00021973287,0.00012920595,0.00021106389,0.000085725864,0.00016536855,0.0016897564],"category_scores_gemma":[0.00006358298,0.00007826455,0.00017951531,0.00013215888,0.00015040468,0.0001447315,0.00014055529,0.00040257792,0.00028241237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019078192,0.000015962672,0.00027960716,0.00003885611,0.000003484323,0.00004478162,0.000005825157,0.000037320613,0.99785006,0.00012482132,0.000060087008,0.001348373],"study_design_scores_gemma":[0.000028845288,0.00033743554,0.010750134,0.000008641463,0.000019169254,0.0004019177,0.0000495648,0.0011121194,0.9818887,0.00013120462,0.0052675204,0.0000047640156],"about_ca_topic_score_codex":0.00055251154,"about_ca_topic_score_gemma":0.0007845606,"teacher_disagreement_score":0.0016897564,"about_ca_system_score_codex":0.00023564257,"about_ca_system_score_gemma":0.00013608176,"threshold_uncertainty_score":0.005652845},"labels":[],"label_agreement":null},{"id":"W4403966709","doi":"10.1158/2767-9764.crc-23-0489","title":"Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Targeting Solutions (Canada)","funders":"National Cancer Institute","keywords":"Stromal cell; Biology; Pancreatic cancer; Tumor microenvironment; Cancer research; Interactome; Cancer-Associated Fibroblasts; Stroma; Context (archaeology); Fibroblast; Cancer; Computational biology; Immunology; Genetics; Cell culture; Tumor cells; Gene; Immunohistochemistry","score_opus":0.07016927760145636,"score_gpt":0.3771237749787284,"score_spread":0.30695449737727204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403966709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747746,0.0010827491,0.020453244,0.00005787665,0.000016434766,0.00002461649,0.0022146972,0.00009841545,0.001277415],"genre_scores_gemma":[0.9814917,0.0007213213,0.014798345,0.00006341145,0.000010788754,0.00005734158,0.0017677742,0.00004711116,0.0010423077],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998872,0.000014116079,0.0000057376064,0.000045835914,0.000034660985,0.00001236406],"domain_scores_gemma":[0.99981874,0.00006864893,0.000031834512,0.000020689997,0.000045759665,0.0000143419875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001965067,0.00011167525,0.00017669189,0.00037893,0.00021783501,0.00044483895,0.000111480316,0.0002058409,0.00046298542],"category_scores_gemma":[0.0004119058,0.0001120909,0.00016091594,0.00033729462,0.0001775964,0.00012333975,0.00015432967,0.00019829895,0.00023627208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010302866,0.000009798953,0.0107960915,0.00005730057,0.000021606693,0.00013169287,0.00015298699,0.0010239349,0.97834593,0.00015828696,0.00009810085,0.009101262],"study_design_scores_gemma":[0.000012393416,0.00018954044,0.28654358,0.000035332032,0.00011934664,0.001509928,0.0007643362,0.029441694,0.6718912,0.0011351947,0.008309319,0.000048151887],"about_ca_topic_score_codex":0.001073223,"about_ca_topic_score_gemma":0.002274484,"teacher_disagreement_score":0.001073223,"about_ca_system_score_codex":0.00016455454,"about_ca_system_score_gemma":0.00019614842,"threshold_uncertainty_score":0.0021339655},"labels":[],"label_agreement":null},{"id":"W4405072689","doi":"10.1158/2767-9764.crc-24-0522","title":"Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation; Vancouver General Hospital; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; Canadian Cancer Society; University Health Network","funders":"Health Innovation Network South London; AstraZeneca","keywords":"Internal medicine; Oncology; Medicine; Adverse effect; Chemotherapy","score_opus":0.04004157953203048,"score_gpt":0.395896123513038,"score_spread":0.3558545439810075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405072689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975206,0.0016722506,0.00010378617,0.00006158064,0.0000042856013,0.000010023968,0.00028208236,0.0000028016066,0.0003425494],"genre_scores_gemma":[0.99956197,0.00012413284,0.00005487132,0.000016395703,0.000005217791,0.0000039498423,0.00019659249,5.7370937e-7,0.000036287034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955744,0.00014979852,0.0000514114,0.000070635884,0.00011689586,0.000053806383],"domain_scores_gemma":[0.99743134,0.0009794245,0.0010320272,0.000093293034,0.00024224441,0.000221641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009443023,0.00011037969,0.0002324323,0.00033423622,0.00018175798,0.0003564488,0.00015439827,0.00020662077,0.00092006195],"category_scores_gemma":[0.0026068476,0.000065242275,0.0003045927,0.0005928828,0.00016254876,0.00022274021,0.00017439247,0.00034502384,0.000062663334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009284029,0.000027990443,0.99108595,0.00004421648,0.00013821018,0.000067937006,0.000014894846,0.000116635194,0.00031736467,0.000022066226,0.00013770351,0.0070986454],"study_design_scores_gemma":[0.000047084468,0.00038707664,0.99767333,0.000016225236,0.00016646902,0.000446653,0.000038793507,0.0004590305,0.0003148596,0.000063373154,0.0003831529,0.0000039592023],"about_ca_topic_score_codex":0.0012766831,"about_ca_topic_score_gemma":0.0021474885,"teacher_disagreement_score":0.0012766831,"about_ca_system_score_codex":0.0003981233,"about_ca_system_score_gemma":0.0003811558,"threshold_uncertainty_score":0.004993975},"labels":[],"label_agreement":null},{"id":"W4405189264","doi":"10.1158/2767-9764.crc-24-0568","title":"First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Pharmacodynamics; Adverse effect; Medicine; Rash; Pharmacokinetics; Dosing; Immune system; Cmax; Internal medicine; Oncology; Pharmacology; Maximum tolerated dose; Immunology","score_opus":0.22607191293560108,"score_gpt":0.4938563121146675,"score_spread":0.26778439917906643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405189264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958151,0.00075494754,0.00047385227,0.00012128864,0.00003989705,0.0015543458,0.0005093694,0.000057887723,0.0006732458],"genre_scores_gemma":[0.9944074,0.0003306652,0.001201494,0.00038009862,0.00006267259,0.0014113536,0.0005399184,0.000018323459,0.0016480508],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99948573,0.00026390984,0.000021142476,0.00008948904,0.00006276736,0.000077007724],"domain_scores_gemma":[0.99933606,0.00009686025,0.00015668578,0.00006651396,0.00006834912,0.00027555812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024184368,0.0010473996,0.001161629,0.00020038188,0.00058981986,0.0005965377,0.0005599065,0.0010384925,0.0036385597],"category_scores_gemma":[0.0008562188,0.0004915304,0.0007360405,0.00017560588,0.00058142876,0.0005999849,0.00030560084,0.001998787,0.0009884523],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5707382,0.089630984,0.043126494,0.0010135091,0.0021336586,0.00046410813,0.00066995405,0.0014457471,0.18095697,0.00024574908,0.0036511319,0.105923526],"study_design_scores_gemma":[0.1297663,0.81791854,0.03488312,0.00003150149,0.00056406774,0.00039449125,0.0001025251,0.0005882916,0.010549405,0.0001753276,0.0049980427,0.00002839595],"about_ca_topic_score_codex":0.0004638176,"about_ca_topic_score_gemma":0.0017997907,"teacher_disagreement_score":0.0036385597,"about_ca_system_score_codex":0.0005927074,"about_ca_system_score_gemma":0.0011243492,"threshold_uncertainty_score":0.012790084},"labels":[],"label_agreement":null},{"id":"W4405797009","doi":"10.1158/2767-9764.crc-24-0287","title":"Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba; IGNIS Innovation (Canada); Jewish General Hospital; Research Institute in Oncology and Hematology; McGill University; CancerCare Manitoba","funders":"National Cancer Institute; Warren Y. Soper Charitable Trust; Fondation De Famille Alvin Segal; Jewish General Hospital; Fondation du cancer du sein du Québec; Genome Canada; Faculty of Medicine, McGill University; McGill University","keywords":"Druggability; Proteomics; Breast cancer; Ductal carcinoma; PI3K/AKT/mTOR pathway; Biology; Quantitative proteomics; Cancer; Bioinformatics; Cancer research; Medicine; Computational biology; Oncology; Pathology; Internal medicine; Gene; Signal transduction; Genetics","score_opus":0.12778570349092808,"score_gpt":0.4749458926351294,"score_spread":0.3471601891442013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405797009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977084,0.006483295,0.010208442,0.0015616718,0.00004962758,0.000081342776,0.0012617945,0.00019452156,0.003075381],"genre_scores_gemma":[0.99117905,0.0018397655,0.0053158235,0.0004641957,0.000037787064,0.000033722325,0.00047796968,0.000022326027,0.0006293851],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995771,0.00009489054,0.00003167732,0.00012240451,0.000120151075,0.000053840606],"domain_scores_gemma":[0.9995733,0.000100039986,0.00015536918,0.00004387307,0.00007767789,0.000049688155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011169588,0.000522076,0.00043466658,0.0008130342,0.00024125671,0.0012575286,0.00024626503,0.0005748544,0.0013444928],"category_scores_gemma":[0.0012231789,0.00019303897,0.00022710918,0.00064523896,0.00039241026,0.00055270985,0.0006037169,0.00057919585,0.00051084993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012974658,0.00031950022,0.24720846,0.0006763147,0.0002758877,0.0006226832,0.00024656937,0.0023409761,0.6406668,0.0012151028,0.0025501538,0.1025801],"study_design_scores_gemma":[0.00008667571,0.0013187216,0.6272129,0.00018877503,0.00043131536,0.0043837507,0.00081311236,0.018576423,0.32546878,0.00724959,0.014190486,0.0000794191],"about_ca_topic_score_codex":0.0002708102,"about_ca_topic_score_gemma":0.00045487948,"teacher_disagreement_score":0.0013444928,"about_ca_system_score_codex":0.00043517607,"about_ca_system_score_gemma":0.0004321136,"threshold_uncertainty_score":0.0059071183},"labels":[],"label_agreement":null},{"id":"W4406215254","doi":"10.1158/2767-9764.crc-24-0566","title":"Evaluating Ovarian Cancer Risk–Reducing Salpingectomy Acceptance: A Survey","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Salpingectomy; Ovarian cancer; Medicine; Population; Gynecology; Demography; Obstetrics; Incidence (geometry); Risk assessment; Cancer; Oncology; Environmental health; Internal medicine; Pregnancy; Biology","score_opus":0.36091268936756304,"score_gpt":0.5806585139827994,"score_spread":0.2197458246152364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406215254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977095,0.00012190708,0.00012098931,0.000373817,0.0000100791685,0.00014157283,0.000629903,0.0000070749834,0.0008851425],"genre_scores_gemma":[0.9976762,0.00033392585,0.00046356302,0.00052270445,0.00001474878,0.0001702468,0.0004355532,0.0000042825723,0.00037876397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983741,0.00052968826,0.00023852597,0.00014148188,0.00044760318,0.00026858097],"domain_scores_gemma":[0.99354494,0.0014387231,0.0019461206,0.00020416177,0.0014493379,0.0014167676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037606035,0.00015332566,0.00029986523,0.00075329933,0.00066946214,0.00075303053,0.0004070045,0.00072451227,0.002103361],"category_scores_gemma":[0.0070984983,0.00033309104,0.00051156303,0.00066245464,0.0004291584,0.0008126763,0.00080310844,0.0010496291,0.0005584001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061940955,0.000263272,0.9851747,0.00014790124,0.000037243426,0.00009062602,0.0044733556,0.00004984871,0.0002752436,0.000047878773,0.0012990483,0.008078939],"study_design_scores_gemma":[0.000020175554,0.00045119866,0.98635733,0.00009716153,0.000020900057,0.00020218613,0.009553034,0.00034584492,0.00011268173,0.000038231778,0.002778897,0.00002225521],"about_ca_topic_score_codex":0.018063156,"about_ca_topic_score_gemma":0.01839444,"teacher_disagreement_score":0.018063156,"about_ca_system_score_codex":0.0009571243,"about_ca_system_score_gemma":0.0012352985,"threshold_uncertainty_score":0.03591603},"labels":[],"label_agreement":null},{"id":"W4406327402","doi":"10.1158/2767-9764.crc-24-0386","title":"Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"GNAQ; Carcinogenesis; Melanoma; Cancer research; Biology; Pathology; Medicine; Cancer; Mutation; Genetics; Gene","score_opus":0.08542991706878349,"score_gpt":0.4099424133787871,"score_spread":0.3245124963100036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406327402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980812,0.00040611735,0.00052009616,0.000040533203,0.000009149639,0.000011676056,0.00018865814,0.000052400916,0.0006900769],"genre_scores_gemma":[0.99414474,0.0002650814,0.0007767251,0.000022747374,0.0000040517502,0.000019550735,0.000364721,0.000025718695,0.004376573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987185,0.000015901222,0.000014546901,0.000024773966,0.00003659212,0.000036348374],"domain_scores_gemma":[0.99981743,0.000023931121,0.000048090667,0.000023227665,0.000011464879,0.00007593424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012278974,0.00039316944,0.00014933148,0.00035834234,0.00016719711,0.00019822257,0.00017397308,0.00036672922,0.0019567572],"category_scores_gemma":[0.0000896371,0.00014710752,0.00021073551,0.00010970789,0.00022186292,0.00016581427,0.0002085569,0.00054319756,0.0005153779],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056838893,0.000023796762,0.00020989007,0.0000081986,0.0000012630611,0.00004063778,0.0000072669454,0.000012419083,0.99929917,0.000025016878,0.000011380068,0.00030411847],"study_design_scores_gemma":[0.00001848941,0.0004479769,0.009607731,0.00000623369,0.000008953865,0.00059469533,0.00003638801,0.000595047,0.98698515,0.000029432886,0.0016669554,0.0000029640469],"about_ca_topic_score_codex":0.00073609286,"about_ca_topic_score_gemma":0.0013275228,"teacher_disagreement_score":0.0019567572,"about_ca_system_score_codex":0.00026819913,"about_ca_system_score_gemma":0.0001503413,"threshold_uncertainty_score":0.0065460205},"labels":[],"label_agreement":null},{"id":"W4406687228","doi":"10.1158/2767-9764.crc-24-0403","title":"Development of a Microvessel Density Gene Signature and Its Application in Precision Medicine","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Eisai","keywords":"Signature (topology); Computational biology; Computer science; Biology; Mathematics","score_opus":0.06631634063185135,"score_gpt":0.42921370317800184,"score_spread":0.36289736254615046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406687228","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7832143,0.0053564818,0.19951169,0.0005897893,0.00009761825,0.00022073089,0.0066340026,0.0011905739,0.0031848557],"genre_scores_gemma":[0.9059648,0.00081337686,0.089252464,0.00014460976,0.000046528665,0.00014607374,0.0029772555,0.000039066108,0.00061567087],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99944574,0.00010464754,0.000049224676,0.00018416833,0.00017717073,0.000039052797],"domain_scores_gemma":[0.9991242,0.00022535543,0.00032520547,0.000060781324,0.00020345658,0.000061086466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010857919,0.00036207764,0.000470627,0.0018580015,0.00013768142,0.0006775354,0.00029985723,0.00031811386,0.00066741783],"category_scores_gemma":[0.0014845874,0.00016699494,0.0003835096,0.0014570298,0.0002447774,0.00026778926,0.0004388964,0.00038622264,0.00021949396],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094711134,0.00023573823,0.24398926,0.0006364914,0.00044659997,0.0002231846,0.00012890794,0.018130358,0.3498475,0.0023255048,0.0035301382,0.37955916],"study_design_scores_gemma":[0.00013376771,0.0012012774,0.34145093,0.00013193469,0.00052150915,0.0014355129,0.0001254202,0.29861647,0.33487412,0.0056445776,0.01573633,0.00012808884],"about_ca_topic_score_codex":0.0008491283,"about_ca_topic_score_gemma":0.0008936279,"teacher_disagreement_score":0.0018580015,"about_ca_system_score_codex":0.0005582705,"about_ca_system_score_gemma":0.0004827443,"threshold_uncertainty_score":0.005742252},"labels":[],"label_agreement":null},{"id":"W4407081872","doi":"10.1158/2767-9764.crc-24-0601","title":"Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; F. Hoffmann-La Roche","keywords":"Pembrolizumab; Metastatic melanoma; Medicine; Oncology; Melanoma; Internal medicine; Immunotherapy; Cancer research; Cancer","score_opus":0.15698857520298767,"score_gpt":0.5087172314434762,"score_spread":0.35172865624048855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407081872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959269,0.0012797352,0.00042753448,0.00017122945,0.00006760019,0.001025508,0.00022780754,0.000046762085,0.0008268937],"genre_scores_gemma":[0.99574524,0.00077252596,0.0009906341,0.00022217301,0.0001238869,0.00075254083,0.00056036253,0.000014590854,0.00081809546],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99962175,0.0001779384,0.000023447865,0.000057933492,0.00004766806,0.00007117343],"domain_scores_gemma":[0.9996289,0.000045451685,0.00009649663,0.000028820841,0.000025195539,0.00017514742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010776232,0.001050675,0.0014631086,0.000296982,0.0003185196,0.0007446316,0.0005896155,0.00065452914,0.0018670638],"category_scores_gemma":[0.0004751207,0.00041489673,0.00073270197,0.00023599491,0.0005935616,0.00044462402,0.00022467456,0.0021721253,0.00057448744],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40629226,0.12003554,0.016953185,0.0011368365,0.0016653126,0.00049909466,0.00039978843,0.0035711695,0.28131482,0.0003059719,0.002898503,0.16492753],"study_design_scores_gemma":[0.24672091,0.7053559,0.015120901,0.000049982118,0.00055650866,0.0005763228,0.00008091603,0.0016009668,0.026346061,0.00010669433,0.0034618087,0.000023027926],"about_ca_topic_score_codex":0.00087944075,"about_ca_topic_score_gemma":0.0020315323,"teacher_disagreement_score":0.0018670638,"about_ca_system_score_codex":0.00077647355,"about_ca_system_score_gemma":0.0014061849,"threshold_uncertainty_score":0.006245911},"labels":[],"label_agreement":null},{"id":"W4407296520","doi":"10.1158/2767-9764.crc-24-0407","title":"Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bayer","keywords":"Nivolumab; Medicine; Tolerability; Adverse effect; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Clinical trial; Immunotherapy","score_opus":0.04313230397912114,"score_gpt":0.43944991981068704,"score_spread":0.3963176158315659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407296520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965029,0.0018621667,0.0002544341,0.00018671673,0.00002975528,0.00036613774,0.0001479126,0.000031812557,0.0006182111],"genre_scores_gemma":[0.9971124,0.00077374966,0.00069665536,0.00029531965,0.000068015564,0.0003230428,0.00036641498,0.000009542003,0.00035478853],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996221,0.00015900441,0.000028630417,0.00007897441,0.0000568256,0.000054445714],"domain_scores_gemma":[0.9995621,0.00005793307,0.000113247916,0.000036019897,0.00003389767,0.00019691244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009257257,0.00079260446,0.001335535,0.0002836591,0.0003558463,0.00065571413,0.00048540052,0.00072000833,0.001197206],"category_scores_gemma":[0.0006038346,0.00031398502,0.00083555514,0.00028295032,0.0005847092,0.00046395333,0.00020762737,0.0020303947,0.00041224522],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36901298,0.110672064,0.04036192,0.001751517,0.0033192723,0.00075942563,0.0006037532,0.0062487386,0.15239188,0.0002692951,0.005230924,0.30937824],"study_design_scores_gemma":[0.3031383,0.61285,0.05279377,0.000097042095,0.0010658768,0.0011414193,0.00010018195,0.0056285486,0.017127316,0.0002393389,0.005769633,0.000048596554],"about_ca_topic_score_codex":0.0006273241,"about_ca_topic_score_gemma":0.0015304674,"teacher_disagreement_score":0.001335535,"about_ca_system_score_codex":0.0010853724,"about_ca_system_score_gemma":0.0013414219,"threshold_uncertainty_score":0.007874966},"labels":[],"label_agreement":null},{"id":"W4407803354","doi":"10.1158/2767-9764.crc-24-0638","title":"Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"Genentech; Symphogen; BeiGene; AstraZeneca; Pfizer","keywords":"Atezolizumab; Medicine; Solid tumor; Cancer research; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.04126457459301598,"score_gpt":0.33491896054358083,"score_spread":0.29365438595056487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407803354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977368,0.0013164598,0.00023260721,0.00008517588,0.000017590888,0.000088879766,0.00010797564,0.000029651024,0.00038484685],"genre_scores_gemma":[0.9986386,0.00040977902,0.00028465738,0.00008315759,0.000027528346,0.00006227277,0.00021067631,0.0000040464024,0.00027930393],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997595,0.00008431528,0.000025367854,0.00004875254,0.00004882643,0.000033175587],"domain_scores_gemma":[0.99973375,0.000052188545,0.00008931614,0.000031339343,0.000016850212,0.00007667328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053680746,0.00047422302,0.0009976294,0.00022086756,0.00018208113,0.00036998114,0.00027025337,0.00048093608,0.00071719475],"category_scores_gemma":[0.00047905566,0.0001741716,0.00055870943,0.00020015312,0.00037077433,0.00034670878,0.00016409671,0.0011237153,0.00029197405],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1830986,0.029144865,0.03884728,0.0010063841,0.0013623215,0.0012653843,0.00040344222,0.005758948,0.39374062,0.00018975254,0.0024808135,0.34270155],"study_design_scores_gemma":[0.060445175,0.79053456,0.08517047,0.000058469286,0.0009098028,0.0024723457,0.0001091183,0.0041265045,0.049942497,0.00012119741,0.006067548,0.00004233803],"about_ca_topic_score_codex":0.00030502304,"about_ca_topic_score_gemma":0.00083468534,"teacher_disagreement_score":0.0009976294,"about_ca_system_score_codex":0.00038610777,"about_ca_system_score_gemma":0.00040891345,"threshold_uncertainty_score":0.0028389692},"labels":[],"label_agreement":null},{"id":"W4410313621","doi":"10.1158/2767-9764.crc-24-0565","title":"First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Eisai; AstraZeneca","keywords":"Antibody; Medicine; Oncology; Solid tumor; Internal medicine; Expanded access; Cancer research; Cancer; Immunology","score_opus":0.05366742063695047,"score_gpt":0.47217865033405315,"score_spread":0.4185112296971027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410313621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911608,0.0027553544,0.0009939601,0.00031157883,0.000120368946,0.0018215141,0.001140653,0.00009635872,0.0015994463],"genre_scores_gemma":[0.9908343,0.0011369919,0.001663675,0.0009181029,0.00019713509,0.001187475,0.0019286207,0.000034052322,0.0020996963],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99923086,0.00040032397,0.000042610627,0.000115801406,0.000075022566,0.00013531714],"domain_scores_gemma":[0.9986821,0.0001817664,0.00033104036,0.00016264622,0.00008776055,0.0005546675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025909017,0.0016138087,0.0022708317,0.0002896125,0.0004924001,0.0008919457,0.0007276336,0.0011495994,0.0036554935],"category_scores_gemma":[0.001067561,0.00058898755,0.0012634185,0.00034060513,0.0011308796,0.000987558,0.00032270374,0.0033029013,0.0010513704],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60062647,0.11832862,0.025852816,0.0011905084,0.0022344855,0.0007290553,0.00042142128,0.0025001185,0.11928712,0.00031897277,0.0050507346,0.12345975],"study_design_scores_gemma":[0.16593666,0.80314004,0.015614158,0.00003078569,0.0004365099,0.0006151786,0.0000470518,0.00087706925,0.00933184,0.00010422932,0.003842502,0.00002396721],"about_ca_topic_score_codex":0.0006809163,"about_ca_topic_score_gemma":0.0016619184,"teacher_disagreement_score":0.0036554935,"about_ca_system_score_codex":0.0013592326,"about_ca_system_score_gemma":0.0015704818,"threshold_uncertainty_score":0.013702154},"labels":[],"label_agreement":null},{"id":"W4412155405","doi":"10.1158/2767-9764.crc-25-0080","title":"Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hospital for Sick Children; Children's Hospital of Eastern Ontario; McGill University; University of Calgary; Ontario Institute for Cancer Research; University of Toronto; Dalhousie University","funders":"","keywords":"Zebrafish; Medicine; Oncology; Internal medicine; Biology; Genetics; Gene","score_opus":0.06799869772182086,"score_gpt":0.44204287711510293,"score_spread":0.37404417939328205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412155405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62828153,0.00743336,0.33249277,0.0033900933,0.00035659733,0.00090299995,0.008631109,0.0022557233,0.01625598],"genre_scores_gemma":[0.8731196,0.0055636,0.11329045,0.00058725505,0.000026804772,0.0005416637,0.0023570573,0.00019849498,0.0043150983],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997615,0.000045736975,0.000014938931,0.000047339825,0.000098308876,0.00003213496],"domain_scores_gemma":[0.999793,0.00005348005,0.00005676923,0.000023750423,0.000047201025,0.000025825379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070054317,0.00058632373,0.00034663873,0.0004544255,0.00026866567,0.0006665902,0.0005598691,0.0006459527,0.0014957992],"category_scores_gemma":[0.00063187786,0.00032670042,0.00058034697,0.00016662419,0.00042394717,0.0005404722,0.0008693736,0.0011063173,0.00034419744],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027819254,0.00009473993,0.013217701,0.0005191307,0.00008810173,0.00046861082,0.00017632257,0.048816077,0.90053,0.0064809616,0.0037535068,0.025576698],"study_design_scores_gemma":[0.0001626034,0.0026555546,0.024772067,0.00038848267,0.00039882524,0.0015349477,0.0004607573,0.23700356,0.6539992,0.0070296177,0.07142903,0.00016528032],"about_ca_topic_score_codex":0.008172972,"about_ca_topic_score_gemma":0.015547188,"teacher_disagreement_score":0.008172972,"about_ca_system_score_codex":0.001651257,"about_ca_system_score_gemma":0.0015584915,"threshold_uncertainty_score":0.01625079},"labels":[],"label_agreement":null},{"id":"W4412974237","doi":"10.1158/2767-9764.crc-25-0019","title":"Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Alberta; Spinal Cord Injury BC; Ontario Institute for Cancer Research; Jewish General Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Merck Canada; National Cancer Institute; Incyte; Memorial Sloan-Kettering Cancer Center; BeiGene; AstraZeneca; Celgene; Gilead Sciences","keywords":"Medicine; Internal medicine; Discontinuation; Nausea; Adverse effect; Oncology; Breast cancer; Metastatic breast cancer; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical endpoint; Phases of clinical research; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.3892141963931314,"score_gpt":0.6154104701398585,"score_spread":0.22619627374672713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412974237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917304,0.0009569377,0.00070530566,0.00022978359,0.00006895072,0.004751284,0.0007115693,0.000050613988,0.0007951934],"genre_scores_gemma":[0.9910124,0.00048053407,0.0015643549,0.00040997512,0.0000785013,0.0045966846,0.0005944744,0.000014843205,0.001248284],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991272,0.0005497854,0.000042153908,0.00011061775,0.00008266718,0.00008762384],"domain_scores_gemma":[0.9990337,0.00021603957,0.00027387214,0.00007723172,0.000115058254,0.00028408266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031533495,0.00091274455,0.00088701054,0.00019532183,0.00031938654,0.00046854332,0.00044357477,0.00087268103,0.0036758294],"category_scores_gemma":[0.001651894,0.00037902413,0.0007677872,0.00018463082,0.00049414235,0.0005790808,0.00026300503,0.0015194591,0.00063608115],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8069577,0.051229853,0.02228033,0.00096908485,0.0014834346,0.0001807352,0.00038820275,0.0007665917,0.049918678,0.0002489433,0.0023280662,0.063248366],"study_design_scores_gemma":[0.47143468,0.4957244,0.023654077,0.000044909928,0.0005032258,0.00020383336,0.000070872295,0.00073630444,0.004237337,0.00021495386,0.0031574513,0.00001798618],"about_ca_topic_score_codex":0.00051668775,"about_ca_topic_score_gemma":0.0014816928,"teacher_disagreement_score":0.0036758294,"about_ca_system_score_codex":0.00052010093,"about_ca_system_score_gemma":0.001440089,"threshold_uncertainty_score":0.016676724},"labels":[],"label_agreement":null},{"id":"W4415280517","doi":"10.1158/2767-9764.crc-25-0305","title":"The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Pharmaceuticals Bayer; Ipsen; Astellas Pharma; Eisai; Gilead Sciences; Pfizer; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Cisplatin; Solid tumor; Clinical trial; Cancer; Phases of clinical research; Ataxia-telangiectasia","score_opus":0.02733874823644689,"score_gpt":0.3955000211396913,"score_spread":0.3681612729032444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415280517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99014485,0.004321536,0.00043059848,0.0006707175,0.000074481606,0.0010372975,0.00056982966,0.00013571608,0.0026148993],"genre_scores_gemma":[0.9886651,0.00337059,0.001981654,0.000783908,0.00014738904,0.0009358612,0.0018395691,0.000025438714,0.0022505461],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99970007,0.0001563432,0.000017366581,0.000051930212,0.000036773814,0.00003741652],"domain_scores_gemma":[0.99960524,0.000058554975,0.00010315552,0.000030183657,0.00003097973,0.00017187416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012825265,0.00076354324,0.0010031994,0.00031044532,0.000340743,0.00057264534,0.00083453424,0.0006141177,0.0022763894],"category_scores_gemma":[0.00056152156,0.0003469844,0.00056402734,0.00043192168,0.0006005137,0.00038993658,0.00029467407,0.0020037307,0.00040477657],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4266027,0.05635239,0.033989467,0.002443792,0.0035441706,0.00045199814,0.0004524378,0.010548329,0.07057407,0.0006367737,0.025806293,0.36859754],"study_design_scores_gemma":[0.55329555,0.3790205,0.04110887,0.0001566332,0.0017083155,0.00063865556,0.00007922991,0.003867909,0.006712373,0.00015120754,0.01321297,0.00004773186],"about_ca_topic_score_codex":0.0030289753,"about_ca_topic_score_gemma":0.010379416,"teacher_disagreement_score":0.0030289753,"about_ca_system_score_codex":0.0011800256,"about_ca_system_score_gemma":0.0017840941,"threshold_uncertainty_score":0.00856173},"labels":[],"label_agreement":null},{"id":"W4415437777","doi":"10.1158/2767-9764.crc-25-0346","title":"Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Waterloo; Wilfrid Laurier University; Université Laval; Centre hospitalier de l'Université Laval; Kingston Health Sciences Centre; Interior Health; University Health Network; Ottawa Hospital; Centre hospitalier universitaire de Québec; BC Cancer Agency; Research Canada; University of Alberta; University of Toronto; Toronto Public Health; Cancer Care South East; Public Health Ontario; Ontario Institute for Cancer Research","funders":"Canadian Cancer Society; Pfizer Canada; Government of Ontario; Memorial Sloan-Kettering Cancer Center; Pfizer","keywords":"Palbociclib; Liquid biopsy; Dosing; Breast cancer; Profiling (computer programming); Clinical trial","score_opus":0.08343511337705574,"score_gpt":0.48942236705346986,"score_spread":0.40598725367641414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415437777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728126,0.006407892,0.00047981332,0.0007459713,0.00017319541,0.0007779191,0.000872046,0.0001234319,0.0031384497],"genre_scores_gemma":[0.993789,0.0010719242,0.00085417094,0.0004383309,0.00020820112,0.0010554229,0.00092413893,0.000020690768,0.0016380614],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998635,0.0009527945,0.000041062056,0.00015770145,0.000105624014,0.000107809625],"domain_scores_gemma":[0.9988593,0.00046120468,0.00031588812,0.00009725545,0.000047358935,0.0002189713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026148106,0.000942863,0.0016392401,0.0004624823,0.00020828228,0.0008974141,0.0009037391,0.0008895293,0.0043011396],"category_scores_gemma":[0.002856894,0.00036343586,0.0009953504,0.00048125593,0.000684856,0.000917584,0.0003804035,0.0022469724,0.000586783],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.918771,0.0032497174,0.0040833424,0.0004381662,0.0011756145,0.00004265532,0.00006366167,0.0010742878,0.0057821563,0.00031500857,0.002293923,0.06271039],"study_design_scores_gemma":[0.7802158,0.18213977,0.02451359,0.0001259129,0.0018261384,0.00018396573,0.000066360175,0.005092412,0.0016403631,0.0006798471,0.003483306,0.00003249279],"about_ca_topic_score_codex":0.001845685,"about_ca_topic_score_gemma":0.0053844526,"teacher_disagreement_score":0.0043011396,"about_ca_system_score_codex":0.0015219157,"about_ca_system_score_gemma":0.000974034,"threshold_uncertainty_score":0.01438874},"labels":[],"label_agreement":null},{"id":"W4416369016","doi":"10.1158/2767-9764.crc-25-0564","title":"Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer; Lung cancer; Prostate cancer; Breast cancer; Latin Americans; Incidence (geometry); Colorectal cancer; Epidemiology","score_opus":0.17848345404839586,"score_gpt":0.5065015263874924,"score_spread":0.3280180723390965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416369016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039278213,0.89594966,0.0016468822,0.0022359577,0.00029324766,0.0002810649,0.05788627,0.00013677699,0.0022919634],"genre_scores_gemma":[0.33418632,0.61350346,0.004856035,0.0023125692,0.00032811685,0.0016162958,0.042333387,0.000103513536,0.0007604038],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.994605,0.0019373444,0.0014611249,0.000604453,0.0012235452,0.00016847036],"domain_scores_gemma":[0.9848942,0.0049358862,0.003826897,0.00089267374,0.0051082014,0.00034212586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010751212,0.0009852566,0.0019650683,0.013589769,0.00035093055,0.0015044264,0.0008173196,0.00060077937,0.0010969897],"category_scores_gemma":[0.029370518,0.0006525117,0.0045529637,0.026096486,0.0004340517,0.00075609994,0.0015595203,0.0007336228,0.00022254215],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005288759,0.000040721752,0.57585216,0.10632212,0.04489784,0.00037866583,0.0020128589,0.0027722141,0.00058281916,0.0013498316,0.054560956,0.21070093],"study_design_scores_gemma":[0.00025348162,0.00009343486,0.7869109,0.070136294,0.032193925,0.0006031075,0.0018043092,0.0016713706,0.00042570473,0.00078133785,0.104963645,0.00016247349],"about_ca_topic_score_codex":0.2127726,"about_ca_topic_score_gemma":0.22792667,"teacher_disagreement_score":0.2127726,"about_ca_system_score_codex":0.0032294393,"about_ca_system_score_gemma":0.007350101,"threshold_uncertainty_score":0.42306828},"labels":[],"label_agreement":null},{"id":"W4417247612","doi":"10.1158/2767-9764.crc-25-0419","title":"Extrachromosomal microDNA Signature as a Candidate Biomarker in Pediatric Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; National Research Council Canada; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Centre de recherche du CHU Sainte-Justine; Leukemia and Lymphoma Society of Canada; Canadian Cancer Society; Leukemia and Lymphoma Society","keywords":"Disease; Biomarker; Lymphoblastic Leukemia; Signature (topology); Acute lymphocytic leukemia; Gene","score_opus":0.044408700586863935,"score_gpt":0.41466590033909495,"score_spread":0.37025719975223104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417247612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99699926,0.0020236296,0.00053736795,0.000035725556,0.000006160927,0.00000879183,0.00018861401,0.000014496894,0.00018600815],"genre_scores_gemma":[0.99712723,0.00070962176,0.0015802892,0.000032708365,0.000019287541,0.000016264987,0.00034689164,0.0000036237934,0.00016411085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998548,0.000038724396,0.00001119239,0.000032642693,0.000041378742,0.000021274638],"domain_scores_gemma":[0.99961984,0.00012770729,0.0001482239,0.000013694769,0.000037701167,0.00005278195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021705154,0.00021585515,0.00034243494,0.00096524257,0.00010615966,0.0003691535,0.0001261874,0.00018182228,0.0005161997],"category_scores_gemma":[0.0006916757,0.00011583316,0.00011219044,0.000731087,0.00016978479,0.0001910003,0.00025914563,0.00019444106,0.00014401892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023625873,0.00008706426,0.6926042,0.000236475,0.00009926432,0.00051055546,0.00014285777,0.00085582584,0.25609362,0.000111734946,0.00024435224,0.046651427],"study_design_scores_gemma":[0.000027685288,0.00084133935,0.9560726,0.000023161612,0.00012097708,0.0021827866,0.00018059464,0.0028586774,0.035481196,0.00024950714,0.0019494273,0.000012101221],"about_ca_topic_score_codex":0.00017989056,"about_ca_topic_score_gemma":0.0002837897,"teacher_disagreement_score":0.00096524257,"about_ca_system_score_codex":0.00012066874,"about_ca_system_score_gemma":0.000101681115,"threshold_uncertainty_score":0.0017268658},"labels":[],"label_agreement":null}]}